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Preamble 
Clearly it is important that the medical professjon play a 
sign&ant role in criticaUy evaluating the use of diagnostic 
procedures and therapies in the management or prevention of 
disease states. Rigorous and expert analysis of the available 
data documenting relative benefits and risks of those proce- 
dures and therapies can produce helpful guidelines that im- 
prove the effectiveness of care, optimize patient outcomes. and 
impact the overall cost of care favorably by focusing resources 
on the most effective strategies. 
The American College of Cardiology (ACC) and the Amer- 
ican Heart Association (AHA) have produced such guidelines 
in the area of cardiovascular disease jointly since 1980. This 
report was directed by the ACC/AHA Task Force on Practice 
Guidelines, which has as its charge to develop and revise 
practice guidelines for important cardiovascular diseases and 
procedures. Experts in a given field are selected from both 
organizations to examine subject-specific data and write guide- 
lines. Additional representatives from other medii practitio- 
ner and specialty groups are included in the writing process 
when appropriate. Each writing group is specifically charged to 
perform a formal literature review. weigh the strength of 
evidence for or against a particular treatment or procedure, 
and include estimates of expected health outcomes where data 
exist. Patientspecific modifiers, comorbiiities, and issues of 
patient preference that might inlluence the choice of particular 
tests or therapies are considered along with frequency of 
follow-up and cost-effectiveness. 
These practice guidelines are intended to assist physicians 
in clinicai decision making by describing a range of generally 
acceptable approaches for the diagnosis management, or preven- 
tion of specihc di or conditions. These guidelines attempt to 
defmeprac3icesthatmeettheneedsofrnostpatientsinmost 
circumsmnees. The uhimate judgment regarding care of a partic- 
ular patient must be made hy the physi&n and natient in light of 
aU of the cimrmstanees presented by that patient. 
The ACC”‘iJiA &.&~:io~ J, IL and 111 are used in this 
report to summarize indications for a particular therapy or 
rrcatment as follows: 
Otnss I: Conditions for which tnere is evtdence for an&or 
general agreement that a procedure be performed or a treat- 
ment i\ of benetit. 
Class Ii: Conditions for which there is a divergence of 
evidence dnd%rr opinion about the treatment. 
Class 111: Conditions for which there is evidence andor 
general agreement that the procedure,%eatment is not necessary. 
Tlte Committee to Develop Guidelines on Perioperative Car- 
diiascular EvaJuation for Noncardii Surgery wa chained by 
Kim A. Eagle, MD, and included the folknvmg rneabers: &tree 
H. Rnmdage, MD. Bernard R. Chartmart, MD. Gc;d~n A. Ewy, 
MD, Lee A H&her, MD, Norman R. Hertz.; MC, retfrey A. 
leppo, MD. Thomas Ryan. MD, Robert C. :t%Jant MD. Wil- 
liam H. Spencer JR, MD, John A. SphteJJ, Jr. MD. and Richard 
D. Tw&, MD. Tbii document was approved by thr AK Roard 
of Trustees and the AHA SACC&ering Committee and is 
being pubhhihed simultanwusly in the lownal of.& .4mt+‘can 
Co&g of Cardiidogv and Circulati in March 1996. The dock- 
ment wm aJso endorsed by the tiety for Cardiovascular Anes- 
thesiologkts. the Society for Vascular Surgery, and the North 
American Chapter of the Internatkrnal .%ciety for Cardicwm- 
lar Surgery. 
This document was reviewed hy three outside reviewers nom- 
inated by the XC and by three outside reviewers nominated 
by the AHA, as well as reviewers nominated by the American 
Academy of Family Physicians, the Sociity for Vascular Sur- 
gery, the American Sodety of Anesthesiiogists. and the 
Society of Cardiovascular AnesthesioJogists. The document 
will be +viewed Z years after the date of publication and year& 
thereafter and considered current unkrs the Task Force 
publishes a revision or withdrawal. 
James L. Rirchie, MD. FACC 
Chair, ACC!AHA Task Fwce on Ractice Guidelines 
Exebutive Summary 
Purpose of These cuidehes 
These guidelines are intended for phy&ans involved in the 
preoperative, operative, and postoperative care of patients 
undergoing IKMWK%W surgery. They provide a framework for 
consideringeardiaeri&ofmmcardiisurgeryinavarietyd 
patient and operatrve situations. The overriding theme of these 
guidelines is that intervention is rarely necessary to lower the 
risk of surgery. The goal of the task force is the rational use of 
testing in an era of cost containment. 
General Approach 
Successful perioFerative evaluation and trea:ment of car- 
diac patients undergoing noncardiac surge? requires careful 
Learnwork rind communication between patcnt. primary care 
physician. cnesthesid*l. and surgeon. In general, in&a- 
tions for further cardtac testing and treatments are the same as 
those in the nonoperative setting. but their timing is dependent 
on such factors as the urgency of noncardiac surgery. the 
patient’s risk factors, and rpeeibc surgical considerations 
Coronary revascula&zation before noncardiac surgery to en- 
able the patient to “get through” the noncardiac procedure is 
appropriate only for a small subset of patients at very high risk. 
Preoperative testing should be limited to circumstances in 
which the results will affect patient treatment and outs A 
xuxervative approach to use of expensive tests and treatments 
I+ recommended. 
Preoperative Clinical Evaluation 
‘Ihc initial history. physical examination. and &ctrocudio- 
graphic (ECG) assessment shot&J focus on i!rc!:!!rs!%r of 
potentiaJJy ssrious cardix din ixhrding coronary artery 
disease (CAD) (eg ptix myocardi.aJ infarction [AIR. angina 
pectoris). congestive heart failure (CHFJ. and eJect&J insta- 
bility teg. symptomatic- arrhythmias). 
In addrtton to identifying the presence of pnxxisting mani- 
fested heart disease. it is essentral to define disease serf&. 
srufiliy. and prior hwafmcnr. Other factors that help determine 
cardiac risk include functional capacity. age. cxrmnrbid condi- 
tions (eg, dies melbtus peripheral vascular dii. renat 
dysfunction. chronic puhnonary disease). and type of surgery 
(vascular procedures and prolonged. comphcated thora&. 
abdominal. and head and neck procedures considered higher 
risk). 
Further beoperative Testirrg to Assess 
CoruuaIy Risk 
Whid, patient5 are most likely to benefit from preoperative 
coronary mrtt and treatment? The lack of adequatel) 
controJJed or randomized clinical trials to &tine the optimal 
evaJua&mstrategyhasJedtothepropJsedaJgorithmbasedon 
collected observational data and expert opinion. A stepwlre 
Bayesian stmtee, tbt relies on ac-essment of clinical markers. 
prior coNmary evanlatiar and treatment. htnaioorl rapcrity. 
and surgery-specific risk is outlined b&w. A fnmrrwlr fur 
determining which patients are c2uxUates for cardiac t&ing is 
presrnted in algorithmic form. SulQssfufusedtheargoritbm 
rcquim an appre&tion for tierem Jevek of risk a@nBabR 
to certain diniil e&u- levels d fimcthnal rauadty. 
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and types of surgery. These are detined below, after which the 
step&y--step aigorithm is reviewed. 
CfjuW f&&us. The major clinical ~~Iiciorx of increased 
perioperative cardiiascular risk are unstable roronary syn- 
dromes stteh as recent MI with evideax of important ischemic 
risk and uuatabk or severe angina; decompensated CHF, 
sign&ant arrhythmias (high-grade atrioveotricular block, 
symptotmtic arriqhh in the presence of underlying heart 
disease, supraventricular arrhythmias with uncontrolled ven- 
tricular rate), and severe valvular disease. 
I- przdictars of increased risk are mild ingina 
peetoris, prior MI, compensated or prior CHF, ski diabetes 
meltitus. Minor pmdiaops of risk am advanced age, abnormal 
e-, rhythm other than sinus, low functional 
capachy, history of stroke, and uncontrofled systemic hyper- 
tensioo. 
l%u&uul Cap&y. Thi measurement can be expressed 
in metabok equivalent (MET) levels. Multipies of the base- 
hneMEXw&ecaubeusedtoexpressaerobicdemandsfor 
spedic atski&. Perioperative cardiac and tong-term risk is 
inmased in patients onable to meet a 4-m demand during 
most ootmal daily activik The Duke Activity Status Index 
andothera&itysc&sprovidetbedinih5anwithasetof 
qicdons to determine a patient’s fm&onal cap&y. Energy 
expe.mlitnre for activities such as eating, dressing, walking 
amuudthehouse,anddi&wash@cantangefrom1to4 
ME&. Chbing a Right of stairs, walking on level ground at 
6.4 kn& ruaniuf ~a short dii, scrubbing flooq or playing 
agane~f~equals4to10NIETEShenuoussportssuchas 
~~~~ and football exceed IO METS. 
Surgery-spedfKcardiactiskofnon- 
eardlaesargetyisre tohvoimpormntfactor%thetypeof 
surgeryitxeIfaodtbedegreeofhemodymu&stremassociated 
with sni-geqe procedures The dmatioo and irttensity of 
awonaryand~s&essorsGlnbehdpfldinestimating 
thehkeMmndofperiopemtivecmdiaceveo~piu&Myfor 
emer%ncy sqery. Surgery-specific risk for noneardiac sur- 
gery call he stratified as hi%, intermediate, and low. ffig4t&k 
r3ufgtq indudes major emergency surgery, par&uMy in the 
ekkrlyiaortieandotkrmajorvasadarsurgery;peripheral 
~surgery;andan~pmlongedprocedures~ 
datedwithktrgeRuidshiftsandlorbloodtos.inren?iediale-risk 
pItndlmindudeearotidendarteratomy,beadandnedt 
surgery, intraperitoneal and intmthom&, orthopedic. and 
pstate surgery. buvisk proixhres indude emkucopii and 
pe&tmfdorstre&meutisofbenef&aassII,amditiomfor 
whichthereiadivergeuceof~au&uopiniiabout 
the tIMmel@ and c&s III, cooditiom for which there is 
*aadhwgenemlagnementthattheprocedunisnot 
8ecessary. 
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angina pectoris unresponsive to medical therapy; unstable 
angina pectoris in most patients: and nondiagnostic or equiv- 
ocal noninvasive test in a brgh-risk patient undergoing a 
high-risk procedure. 
Class II indications (may be helpful) are intermediate-risk 
results during noninvasive testing, nondiagnostic or equivocal 
noninvasive test in a patient at lower risk undergoing a higher 
risk procedure; urgent noncardii surgery in a patient recov- 
ering from acute Ml; and perioperative MI. 
Class III indications (not necessary) are low-risk noncardiac 
surgery in patients with known CAD and low-risk results on 
noninvasive testing; screening for CAD without appropriate 
noninvasive testing: patients who are asymptomatic after cor- 
onary vascularization and have excellent exercise capacity; 
mi!d, stable angina in patients with good left ventricular 
function and low-risk noninvasive test results; patients who are 
not candidates for revascufariration because of concomitant 
illnw; prior technically adequate normal coronary at@gram 
within 5 years; severe left ventricular dysfunction in patients 
not considered candidates for revascularization; and patients 
tmwihing to undergo revascularixation. 
The folknving steps correspond to the algorithm presented 
in Fig 1, page 921. 
Step 1. What is tbe urgency of noncardii surgery? Certain 
emergeucies do not allow time for preoperative cardiac evaf- 
uation Postoperative risk stratification may be appropriate for 
some patients who have not had such an asr6sment before. 
Step 2. Has the patient undergone coronary revasculariza- 
tion in the past 5 years? If 50, and if co ical status has 
remained stable without recurrent symptoms/stgns of ischemia, 
further can&e testing is generaity not necessary. 
Step 3. Has the patient had a coronary evaluatiin in the 
past 2 years? If coronary risk was adequately assessed and the 
findings were favorable, it is usually not rtexxswy to repeat 
testing unless the patient has experienced a change or new 
symptoms of coronary ischemia since the previous evaluation. 
Step 4. Does the patient have an unstable coronary syn- 
drome or a major clinical prediior of risk? When elective 
ooucardmcsurgeryisbeingcooslderedtheprcsenceofumta- 
ble coronary dii, decompensated CHF, symptomat+ ar- 
rhythm&. an&or severe valvutar heart dii usually leads to 
cancellation or delay of surgery until the problem has heen 
identified and treated. 
Step 5. Does the patient have inbmediare clinicalprrdiam 
qf tsk? The presence or absence of prior hit by history or 
ECG, angina pectoris, compensated or prior CHF, and/or 
diabetes meltitus helps further stratify dinical risk for periop 
erative coronary events. Cottsideration of jiu&oaal cafnrciry 
and level of e+@c r+sk allows a rational appmach to 
ideutifying p0tient.s most likely to benefit from further nonin- 
Vaoivetcstmg, 
step 4 Patients without major but with intermediate pre- 
dictors of dinical risk and moderate or excellent fuuctii 
capacity can getteridly undergo imermediate-risk surgery with 
lixklikdiiofpemprativedeathorM1.CaMlody,~ 
waiwarive~bofbwcoosidercdforpRRentsnitepoor 
JACC Vd. 27. No. 4 
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functional capacity or moderate functional capacity but higber- 
rid surgery and e-specialty for patien& with two or more 
intermediate predictors. 
Step 7. Noncardii surgery is generally safe for patients 
with neither major nor intermediate predictors of clinical risk 
and moderate or excellent fimctional capacity (4 METS or 
greater). Further testing stay be cons&red on an individual 
basis for patients without diiical markers but prior fumiional 
cap&y who are facing higher-risk operatiom, particularly 
those with several minor clinical predictors of risk who are IO 
undergo vascular surgery. 
!%epS.Theresultsofnoainvasivetestingcanbeuwdto 
determine further preoperative management. Altemativety, 
tberesultsmayleadtoa recommendation to praxcd with 
surgery. In some patients, the risk of coronary intervention or 
corrective cardiac surgery may apprnacb nr even exceed the 
risk of the proposed noncardiac surgery. Thb approach may k 
appropriate, however, if it also sign&antfy imprwes *e 
patient’s long-term prognosis. 
For some patients, a careful comideration of clinical, 
decision to proceed to coronary aqiogmphy. 
Management of Specifw hpemtive 
tlbdiovasculrrr cooditions 
Hypertwion: Severe hypertension should 5e contrdkd 
before surgery when possible. 3%~ de&ion to delay surgeq 
because of elevated blond pressure should take into account 
the urgency of surgery and potential be&t of more interrsive 
medical therapy. Continuatioa of preopemtive antihypcrten- 
sive treatment througb the perbperative period is critical. 
v*r huvr diIcu.fe: rndications for evaluation and treat- 
nlentofvalvularheartdiseaseareidentkaltothoseintbe 
nonoperative setting Symptomatic stenotic lesions are aswxi- 
atedwitbriskofperbpemtivesevereCHFnrshatandoften 
require percutaneous vabutmq or valve qkwment before 
nmtcardiisuqeiytolowercardiacrisk.SymPormricregur- 
&ant valve disease t5 usually better tolerated pcriqrcrativcty 
and rray be stabilized preoperatively with intensiw medical 
therapy and monitoring. Regurgitant valve disease is then 
mated de&&My with valve repair or qlacement after 
fwncdiic surgery. This is apprqiate a&tx~ a wit of several 
weeks or months &fore noncardiac surgery may baw severe 
c%Jlt?qlJelKcs E.w@ots may indude SKIe valvda3 Ieguh 
gjtation f&h rcduccd kft ventriadar furbon, in vhidr werall 
hemw+miinzserveissolimitedtbatdeSaMWiiduring 
petioperatk-isveryLiLety. 
Anfn’rhmraa and rundtutiun atvmmdtihr The prewncc of 
an arrhythmia or cardxac cwduction dLurhance chwid pw 
voke a careful evaluation for underlying cardicypulmonar), 
disease, drug toxicity. or rnetbolic abnurrnalie. Therap 
should be initiated for symptom& or h&nodynamiAl~ sig 
nificant arrhythmias. fix! to rmersc an underlying LXUUZ and 
second to treat the arrf.jthmia. Indications for &arrhylhmk: 
therapy drd wdlac pacmg arc identical IO the r~mqnx.+~ne 
utling. 
Soppkmeatd Preoperative Evahtioo 
No specific recummendatiom can be made fclr indi\idual 
patients. The folkwing &Ad be awkiered app3ophe as 
indicated in specifd situations: re5ting left wwicular function, 
exercise stress testing. pbannx&gt4 sIr6s t&i* ambula- 
tory ECG rnnnitoring and corunaq ang@@y. In ricst 
ambulatory patients the test of chk j F, cxerciu ECG te\ting. 
whkh cm both p3wide an estimate of functiof& capxiI) and 
detect myocardial ischemia through changes in the ECG and 
hemodynamic respne. In patients with unpoflanurt &normal. 
ities on their resting ECG (kft twndk brash hbck. kft 
ventricular hypcrtrophy with swam pattern. diitAn cllect, 
etc). nther techniques wh as exercise ecbardiqraphy or 
exercise myocdhl petiion imaging sbmdd be ax&bed. 
Impliitioos of Risk Assessment Stratqgies 
oacosts 
The degm uf idri&h~ wmnnnling prwfxr4nr te5ting 
before noncardiac urrgep ir wuhslanri.4, CcM-ektiwnes 
anatps of va3km methods of preoperative testing and tre.31. 
merits have also yiekkd highly wkd results. it k important for 
theclinbantoc0nsiderthecW+nplicatiomnfscreening 
suat~and,wbenpossihle.t03elyongelle~aceepled 
stratqk for treating pa&n& in the nonopnuiw retting. 
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d;sty, including emergency CABG in some patients. Until 
father data are available, indications for PTCA in the peri- 
operative setting are similar to those in the ACCAHA guidc- 
likes for use of PTCA in general. 
Medical T&ram for Cotmaty Artery Disease 
‘Ike are very few randomized trials from which firm 
conclusions or recommendations can be drawn. However, if 
patieots require f3-blockers. calcium channel blockers, and/or 
nitrates before surgery, continuation of the preoperative med- 
ical fegiokeo into the operative and postoperative period may 
ah protect agdnst kchemic tendencies caused by periopera- 
tive stremes. The same is true for therapies to control symp- 
toms of CHF. Observational stud&s also suggest that k 
blockers reduce frequency of postoperative ischemia, and in 
one study reduced incidence of perioperative MB. Protection 
against kheoia may also reduce risk of MI. 
Amesthetic Considerations and 
intnroperative Management 
Aneshic apt: All anesthetic techniques and drugs have 
koowncardiace&ctsthatshouklbeconsideredintheperiop- 
erative plan. There appears to be no one best myocardial 
pmective anesthetic technique. Therefore, the choice of an- 
esthesia and iotraoperative monitors is best left to the discre- 
tion of the anesthesia care team, which will consider the need 
for postoperative ventilation; cardiovascuhu effects, including 
ngomdhl depression, sympathetic bloclade; and dermatomal 
levelofthepmcedme.Advocatesofmonitoredanmthesia,in 
Whidtlocallwslhesiaissuppteme~tedbyintravewusseda- 
tion/M have argued that use of this technipe avoids 
the undesirable etkts of general or oemaxial techniques, but 
no studii have established this. Failure to produce complete 
IocaIamWe&/analgesiacanleadtoincreasedstresire- 
spoltse,myocardiiischemia,ordepresJion. 
Pe&pemnve pain manngcnicnc Patient-controlled iotra- 
venous and/or epidural analgesia is a popular method for 
reducing postoperative pain. Several studies suggest that 
effective pain management leads to a reduction in postop 
erative catecholamine surges and hypercoagulability. 
i~~ti T&e are iosu&cieot data about 
the c&ctS of prOph$h intraoperative intravenous oitrogiyc- 
erin in patients at hi risk. lUitrog,Iycerin should be used only 
when the hemdynamii effects of other agents in use are 
cTcmideTed. 
echacw ci7x): There are few 
ue of m-de- transient wall motion 
~&Jpredict&morbidity~~sur- 
gbIpatier#s.~ilQtodate~thattheiTIcre~otal 
vahteofthistedmiqWforrisk~issmatl.cuidelines 
forappm+teuseofTEEarebeiidevelopedbythe 
AatekansoktyofAnesthesiologishaodthesocietyof 
J.%CC Vol. 27. No. 4 
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Perioperative Surveillance 
Pulmonary arrery cathetererr: Although very few studies that 
have been reported compare palient outcoroes after treatment 
with or without pulmonary artery catheters, the following three 
variables are particularly important in assessing benefit versus 
risk of pulmonary artery catheter use: disease severity, magni- 
tude of anticipated surgery, and practice setting. The extent of 
expected fluid shifts is a primary concern. Patients most likely 
to benefit from perioperative use of a pulmonary artery 
catheter appear to be those with a recent MI complicated by 
CHF, those with significant CAD who are undergoing proce- 
dures associated with significant hemodynamic stress, and 
those with systolic or diastolic left ventricular dysfunction, 
cardiomyopathy, and valvular disease undergoing high-risk 
operations. 
Intraopemtive and postopemtive ST-segment monitorihg: In- 
tmoperative and postoperative ST changes indicating myocar- 
dial ischemia are strong prediiors of perioperative MI in 
patients at high risk who undergo noncardiac surgery. Simi- 
larly, postoperative &hernia is a significant predictor of loog- 
term Ml and cardiac death. Conversely, in patients at low risk 
who undergo noncardiac surgery, ST depression may occur and 
Accumulating evidence suggests that proper use of computer- 
ixed ST-segment analysis in appropriately selected patients at 
high risk may improve sensitivity for myocardial ischemia 
detection. 
Surveilfanceforpehywrative MI: Few studies have examined 
the optimal method for diagnosing a perioperative Ml. Clinical 
symptoms postoperative ECG changes, and elevation of the 
MB fraction of creatine kinase (CK) have been most exten- 
sively studied. Newer myocardii-spe&c enzyme elevations 
such as tropooin-I, troponin-T, or CK-MB isoforms may also 
have value. IO patients with known or suspected CAD under- 
going high-risk procedures, ECGs obtained at b&reline, imme- 
diately after surgery, and the first 2 days after surgery appear to 
be cost-effective. Use of cardiac ew:s is best reserved for 
natieots at high risk and those with clinical, ECG. or hemody- 
namic evidence of cardiiascular dysfunction. 
Postoperative Therapy and 
Lung-Term Management 
When possible, postoperative management should include 
assessment and management of modifiable risk factors for 
CAD, heart failure, hypertension, stroke, and other cardiias- 
CuIar dii For many patients. the proposed noncardiac 
surgery may be the first opportunity for a systematic cardio- 
vascdar evaluatinn. Assessment for hyper&olesterolemi 
somkir& hypertension, diabetes, physii bmctivity, peripheral 
tasadar disease, cardii murmur(s), arrhythmias. amduetii 
almomdties, perioperative ischemia, and postoperative MI 
may Icad to futther evaluation and treatments that reduce 
hdure cardii risk. In particular, patients who sustain a 
perioperative Ml and/or experieace repetitive postoper&e 
JACC Vol. 27. No. 3 
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myocardial ischemia are at substantially high risk for MI or 
cardiac death during long-term follow-up. These patients 
should be a narticutar focus for risk facror intervernions and 
future risk stratification and therapy. 
Development of Guidelines 
These gnidelines are based on a Medline search of the English 
literature from 1975 through 1994, review of selected journak 
from 1995. and the expert opiniins of I2 committee members 
representing various disciplines of cardiiascular care, including 
general cadolo~, noninvasive testing, vascular mediche, vascu- 
lar surgery, anesthesiology and arrhythmia management. In 
addition, draft guidelines were submitted for critical review and 
amendment to ph&ians representing internal medic&. family 
practice, nuclear cardiology, general surgery, and anesthesiology 
as well as executive ot3icers representing the American College of 
C%diologyatldtheAmericanHeartAssociationlbefiMldoC- 
ument represents the eighth iteration over 18 months which 
includedsixdraftsincommitteeandtwoadditionaldraftsto 
incorpomte key tinding horn external review. 
Alargeproportionofthedatausedtodevelopthesegukle- 
li i is based on observational or retroqeztive stndii or know)- 
edge of management of cardiovz&ar dii in the nonop 
erativesetting.Whilethea3Uectiieknavledgesutxm&gthe 
identihcation of &h- and low-risk patients using p&operative 
climcalandnonim~evaluationissubstantiakveryfewpro- 
spestive or randomized studii have been performed that estab- 
lish the value of tests or treatments on perioperative outcomes. 
Therefore, data are presented in a tabular format. and whenever 
pie ret&t the value of a test or intervention for similar 
outcomesofaperioperativeMforcardiacdeath.Becausethe 
stndiiwererarelyrarandomcuacontrolledtriaJs,defimtiarsda 
perioperative event vaii investigators were rarely bhi and 
many inherent selection biases extsted. the task force has chosen 
nottoprovideanaggregatesynthesisofthedataintheformda 
point estimate or meta-analysis. On the other hand. presen- 
tation of the original data provides substantial support for 
these recommendations. 
Guidelines for Perioperative 
Cardiovascular Evaluation for 
Noncardiac Surgery 
I. DetMtioi* of the Prablem 
Purpose of These Guidelines 
These gtridelines are inter&d for phy&ians who are 
involved in the preoperative, operative, and postoperative care 
ofpatientstmdergoingnoncardiacstugmy.lheypmvidea 
framework for considering cardiac risk of nommdmc surgery 
inavarietyofpatientandsu~smutiwrTBetaskforee 
thatpnpaledtheseguidelhtesstlivedtoinaaporate~tis 
curlemJyknowtlaboutpeliopelattiliskandbowtlti5twwl- 
edgecattbensedittlbeindividual*nt.Metlmdslised,to 
devebp- ale6ilsmaditlAppea8hI. 
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The tables and algorithms provide quick references for 
decision making The overriding theme of this document is that 
~~tervsntion is rarely necessilry simply to lower the risk of 
surg:ry ur.!css such intcncntion is indicated irrespective of rhe 
preoperative context. The purpose of preoperative evalua&3n 
is not to give medical clearance but rather to perform an 
evaluation of the patient’s current medical status. make rec- 
ommendations concerning the risk of cardiac problems over 
the entire perioperative period. and provide a clinical risk 
profile that the patient. his or her primary ph-tician. anesthe- 
siologist. and surgeon can use in making treatment de&ons. 
No test shouhi be pfotmed unkss it is like!v IO infhence phi 
rreurmenr. Therefore. the goal of the consultation is the rare- 
nal use of testing in an era of cost containment. 
Epidemiology 
The prevalence of cardiiascular disease increams with age, 
and it is estimated that the number of persons older than 65 
years in the United States will increase 2% to 35% over the 
next 30 years.’ Coincidentally. this is the same age group in 
which the largest number of surgical procedures are per- 
formed.’ Thus. it is conceivable that the number of noncardiac 
surgical procedures performed in older persons will increase 
from the current 6 million to nearly 12 million procedures 
performedper,year,andneartyafourthofthese-majorintra- 
ab&mimt tlmlack vascular, and orthopedic pt-axdules 
havebeenrmociatedwithas&n&cmtperioperative~ 
aJlal?lmwityandmoltality. 
Pmctice Patterns 
There are few reliable data available regarding (I) how 
often a family ph+ian. general internist, subspecialty ittter- 
nist. or surgeon performs a preoperative evaluation on his or 
her own patient without a formal consultation and (2) bow 
often a formal preoperative comadtation is requested from 
eitheragewralistora&9speM&~asacardiifor 
ditferent types d sqical procedures and different categories 
of patients The patterns of pm&e vary signiitly in 
dillerent locations in the country and vary between patients 
receiving care under diaerent healthcam provider systems3 
There is an important need to determine the relative cost- 
effectiveness of different shategies of periopetative waltration. 
In many institutions, patients are evahtated in an armsthe& 
preoperative malpion setting If sufficient informatin about 
the patient’s c?admadar status is available, the symptoms 
arestabte.andhrrtberevahmtiiwiUnotintIuenceperiofXr- 
ative management. a formal consultation may not be required 
nor obtained. This is facihtated by commtmication between 
anesthesiaperr4mnelandphysiciamraponsiMeforthepa- 
Gent’s cardii lalcale. 
Fthanci$Impkatiws 
lllefinancialimplicrtioesdrbkulatiliQtioucaJmotbc 
~i%eneedforbettermethodsofobje++memmkag 
~rkskhasledtotbedRicbpmwtdmuftf#e 
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noninvasive techniques in addition to established invasive 
procedures While a variety of strategies to assess and lower 
cardiac risk have been developed, their aggregate cost has 
received relatively little attention. Given the striking practice 
variation and high costs associated with many evaluation’ 
strategies, the development of practice guidelines based on 
currently available knowledge can serve to foster more ethcient 
approaches to periopemtive evaluation. 
Role of the Consultant 
The consultant should review available patient data, obtain 
a history, and perform a physical examination pertinent to the 
patient’s problem and the proposed surgery. A critical role of 
the con&ant is to communicate the severity and stability of 
the patient’s cardiovascular status and to determine if the 
patient is in the best reasonable medical condition, given the 
context of the surgical illness. The consultant may recommend 
changes in medication and suggest preoperative tests or pro- 
cedures. In some instances, an additional test is necessary 
based on the results of the initial preoperative test In general, 
preoperative teats are recommended only if the information 
obta&dwiUreaultinachangeinthesurgicalprocedureper- 
~acbangeinmedicnlthempyormonitoringduri.ngor 
aftersurgety,orapos@onementofsutgetyuntilthecardii 
amditioncanbecorre&dorstab&ed.Beforesuggestingan 
addit& test, the con&ant slmld feel co&dent that the 
u&matkmitpmvideswillprovidea~tadditiontothe 
~~~~ ba%e potential to impact treatment. 
avo’ . 
II. General Approach to the Patient 
~cardiacevahtationmustbecarefnllytahoredto 
tlte~thathaveprolnptedtheconsl!ltatkmand 
ltameaftheslngicaliilnessGivenanacute~emergency, 
pmopem&Rmhrationwillbelimitedtoarapidamemmentof 
carhmakvitaisigwvolumestahs,andelectrocardiogram 
(JXf3).Onlythemostessentialtestsandinterventionsare 
tmtiltheaarte.surgimlemergenyismsolved.A 
evahmGmcanbecondu&daftersurgety.ln 
surgeiyisnotpe6rmedrtranemerge~ 
ptxlah%butgcKnicaredictatespromptsurgely.lnpatientsin 
whommyocardial~isnotanopt&itisoftennot 
~~performateat.Underother,lesaurgentc&mr- 
preoperativecardiacevahtationmayleadtoavariety 
ofrt+mseasometimesthissituationmayincludecancellationof 
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otherwise healthy patient may require no further workup or 
special precaution, whereas suspicion of previously unsus- 
pected CAD or CHF in a patient scheduled for an elective 
procedure may justify a more extensive workup.& 
The cardiac consultant must also bear in mind that the 
perioperative evaluation may be the ideal opportunity to 
impact long-term treatment of a patient with sign&ant cardiac 
disease or risk of such disease. The referring physician and 
patient should be informed of the results of the evaluation and 
implications for the patient’s prognosis. The consultant can 
also assist in planning for follow-up. 
Histoy 
A careful history is crucial to the discovery of cardiac and/or 
comorbid diseases that would place the patient in a high 
surgical risk category. The history should seek to identify 
serious cardiac conditions such as prior angina, recent or pat 
Ml, CHF, and symptomatic arrhythmias. Modifiable risk fac- 
tors for coronary heart disease (CHD) should be recorded 
along with evidence of associated d&eases, such as peripheral 
vascular disease, cerebrovascular dii, diabetes mellitus, 
renal impairment, and chronic pulmonary dii. In patients 
with established cardiac disease, any recent change in symp- 
toms must be ascertained. Accurate recording of current 
medications and dosages is essential. Use of alcohol and 
over-theeounter and illicit drugs should be documented. 
The history should also seek to determine the patient’s 
functional capacity (Table 1). An assessment of an indiidual’s 
capacity to perform a spectrum of common daily tasks has been 
shown to correlate well with maximum oxygen uptake by 
treadmill testing.7 A patient classihed as high risk due to age or 
known CAD but who is asymptomatic and runs for 30 minutes 
daily may need no further evaluation. In contrast, a sedentary 
patient without a history of cardiilru disease but with 
clinical factors that suggest increased perioperative risk may 
benefit from a more extensive preoperative evaluation.s~6~9 It 
is important to emphasize that the preoperative consultation 
may represent the first careful cardiovascular evaluation for 
the patient in years, and in some instances, ever. For example, 
inquiry regarding symptoms suggestive of angina or CHF may 
establish or suggest these. diagnoses for the lirst time. 
FSysical Examination 
A careful cardiovascular examination should include an 
assessment of vital signs (including blood pressure in both 
arms), carotid pulse contour and bruits, jugular venous pres- 
sure and pulsation auscultation of the lun)qs, precordii 
~n4IRisuscultatasm~andenami7a- 
-fnredemaand~integrity.More 
-willbedidaredlyspecitic~. 
lhefollovdngpointsareworthen@ta&in~ 
*negeneraiappearaIkccpmvides-evidence 
regarding the patient’s overall status. Cyano& pallor, 
dy!qneaduriugconvem~orwitbminimalactivity, 
puor nutritional stam nhesily. skeletal defOrmitii 
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tremor, and/or anxiety are just a few of the clues that can 
be recognized by the skilled physician. 
e In patients with acute heart failure, pulmonary rales and 
chest x-ray evidence of pulmonary congestion correlate 
well with elevated pulmonary venous pressure. In pa- 
tients with chronic heart failure, however, these findings 
may be absent. An elevated jugular venous pressure or a 
positive hepatojugular reflux are more reliable signs of 
hypetvolemia in these patients.‘uJr Peripheral e&ma is 
not a reliable indicator of chronic heart failure unless the 
jugular venous pressure k elevated or the hepatojugular 
test is positive. 
a A careful examination of the carotid and other arterial 
pukes is essential. The presence of associated vascular 
disease should heighten suspicion of occult CAD. 
@ Cardiac auscultation will often provide useful clues to 
underlying cardiac disease. When present, a third heart 
sound at the apical area suggests a failing left ventricle, but 
its absence is not a reliable indicator of good ventricular 
functionn 
a Ifamurmurispresent,theclmicianwillneedtodecide 
whether or not it repreaenk sign&ant valvuhu disease. 
Detection of significant aortis stenosis is of par&c&r 
importanoebecausethisleaionposesahighrkkfornon- 
cardiac surgeiy.12 Sit mitral stenasis or mgmgita- 
tkXtitlCSWSriskofCHF.AottiC~gurgitationandmitral 
regurgitatioilmaybeminim~yetpredispasethepatientto 
infective eixharditk should bacteremia occur fobowing 
smrgery.Intheseconditio~espaialhifmitralmm;ll 
tionisrheumaticinoriginorduetomitralvalveprolapse, 
consideration must be given to endomrditis pmphyk&r3 
Comorbid Dbeases 
The coosuitant must evahrate the c&&ax&r system within 
the kmework of the patient’s overall health. Associated condi- 
tionsoftenheiitentherir.kofanm&siaandmay~ 
cardiacmanagement.Themostcommon Ofthesed~ille: 
rice of either obstructive or rt&ictive pmmomuy 
dii places the patient at increased risk of developing 
perioperative respiratory compliitions. Hypoxemia, hy,?er- 
capt&acido@andincmased~workofbreathingcanalllead 
to further deterioration of an already compromised card@& 
monarysystem.Ifsigni6cantp&onarydkeaseissuspe&dhy 
history or physii examination, detetmination of functii 
q-=@, respoose to bron&uhlato& a&or evaluation for 
thepresenceofcarbondioxideretentioo~arterial 
bloodgaaanaIysismayhej&i6ed.Iftherekevi&nceof 
infeet& appropriate an- are critical. steroids and 
bronhdiiolamaybeindicatedaltboughtheriskofproduc- 
inga&ythmiiormyocanWkchemiabyBagonisamtktbe 
Avarietyofrnetab&-may~cudiac 
.DiabetertuelIiiktIteiaost aJmmm. Its presxnx 
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should heighten suspicion of CAD, particularly because myo- 
cardial ischemia is more likely to be silent in the patient with 
diabetes mellitus. Management of blood glucose levels in the 
perioperative period may be difficult. Fragile diabetic patients 
need careful treatment with adjusted doses or infusions of 
short-acting insulin based on frequent blood sugar determina- 
tions. More stable diabetic patients may be treated with 
long-acting insulin or oral hypoglycemics. It is acceptable to 
maintain blood glucox at relatively high levels perioperatively 
and it is far preferable to tight control with its attendant risks 
for hypoglycemic episodes 
RenalIF 
Azotemia is commonly associated with cardiac disease and 
often complicates its management. Maintenance of adequate 
intravascular volume for renal perfusion during diuresis of a 
patient with heart failure is often challenging. Excessive diure- 
sis in combination with initiation of angiotensin converting 
enzyme (ACE) inhibiton may result in an increase in blood 
urea nitrogen and plasma creatinine concentrations. 
Discldm 
imposes a stress on the cardiovascular system that 
may exacerbate myocardial ischemia and aggravate CHF.r4 
Preoperative transfusion, when used appropriately in patients 
with advanced CAD and/or CHF. may reduce perioperative 
cardiac morbidity. Hmever, with current concern about pos- 
sible transmission of HIV and hepatitis through the use of 
bbodproduct$a ccmervative approach with respect to trans- 
fusioniswarraoted. 
Po~~~andork-thatin- 
aeasebloodviscositymay illmasetheliskofthromboembdi 
an%rhlmohag.AnnopriatestepstoreducetheserisLs 
should be cousidered and taiiod to the illdad ptient’s 
pamcukr- 
Anci&ty Sauiks 
The amsuhant should rev&v ah available laboratory data. 
Inthiieraofcostcontainmen~thelaboratorydataavaiWe 
may be mbliid. Therefore, the amsuhant may require addi- 
tionaItestssuchasbloodchemkt&andacheatmdiogn+ 
basedonhistoryandphysi&examinatinn.Bloodlevekof 
cardiacdrugs,indu&gdiin.sbouldbeobtamedonIywben 
therearespesc 
remntchangein 
In patients re 
ahnostalwaysindieatedaspartofapreoperativeevah&onIn 
faa.anaItmmaIECGreportkoftentIlereasonthateonsld- 
tationbquestedMetaholkandeiectdyledisturbaaEes 
. . medKam&in-disesre.pufmnnaryd~ete.can 
alter the ECG. conduction rtirttnbanocs such as bude 
bIanchbloctorIirstzkgree-Morr,rnayie8dto 
amcembutusualiydonotjusrifyfurthrrworkup.Thesameis 
often tme 
sigiaani 
htmd,s&tleECGcIueseanpointthe~nytoachnieaIlysiIent 
-ofmajorimporL 
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Table 1. Clinii Predictors of Inneased Perioperative Cardiovasctt- 
lar Risk (Mvocardial :nfaraioo, CIxtResdve Heart Faihtre, Death) 
U~eoronarYW~ 
. Iteeent myoeardisl irdamkd with evidencz of important i&&c risk 
bydhdcalsymptnmoraoniwasiveshldy 
. uttnable ot we& angina (cmmdii’claa III or IV)+ 
Dearmpeosated congestive heat failure 
sl!@caltarrbyrhmiar 
l Highqade atrioventticldm block 
. r veatdctdat mThyutmias in the prcseace of underlying heart 
. Sapmventtie&r arrhythmias with uttm~%~~Iled ventricular rate 
scvmevslvulvdii 
Mod angina pecmis (canadii class I or II) 
Pdor ttpadid ittfarctmn by history or patholqical Q waves 
Compensated or prior cottgestive heart failure 
Diabetes meUittts 
Miaa 
A-age 
Abaomal ECG (leti ventricular hypertraphy, left bundle branch black, ST-T 
abnormalities) 
UttlWtltlOlledsystemichypenensioo 
The basic clii evaluation obtained by history, physical 
examination,andreviewoftheECGusuallyprovidesthe 
consuItant with sufficient data to estimate cardii risk. Table 1 
lists diuii predictors of increased perioperative risk of MI, 
CHF, and death established by several authors based on 
mtdtiwiate anaIy~is.~~~~~ AIthqh some authors have sug- 
gested a scoring system that assigns more weight to some 
factors than others and sums these to arrive at a composite 
r&l- most recent art&s have suggested simpler crite- 
ria.t5-2t In dii pmtice. more weight is attxhed to active 
cotlditions than dormaot Mes$ whii the degree of deviation 
T&k % Wmated Energy Requirements for Vartous Activities’ 
lb4Er cm )W lake cam of yomelf? 4 METS 
I 
I 
Ea~,d?e&oruscthetoikt? 
Walkiadmsarmmdthcbouoe? 
Wdkablockorlwonle*el 
gouodat2-3mpb~332-4.8kmRt? 
Dolightwortrarotmddtcbwrelike 
dWtiUgWss;lshiogd 
4METa 
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from the normis used as an implicit modifier. Table 1 attempts 
to deal with this practice by placing the predictors in the 
following three categories: 
@ Major predictors, when present, mandate intensive man- 
agement, which may result in del;iy or cancellation of 
surgery unless it is emergent. 
l I- predictors are well-validated markers of en- 
hanced risk of perioperative cardiac compiiitions and 
just@ carelid assessment of the patient’s current status. 
l Minor predictors are recognized markers for cardiovas- 
cular disease that have not been proven to independently 
increase periopemtive risk. 
It should be noted that a history of MI or pathological Q 
waves by ECG is listed as an intermediate predictor, whereas 
a recent MI* is a major predictor. In this way the separation of 
MI into the traditional 3- and 6-month intervals has been 
avoided.‘= Current management of MI provides for risk 
stratification during convalescence.~ If a recent stress test does 
not indicate residual myocardium at risk, the likelihood of 
reinfarction after noncardiac surgery is low. Although there 
are no adequate clinical trials on which to base firm recom- 
mendations, it appears reasonable to wait 4 to 6 weeks after MI 
to perform elective surgery. 
Table 2 presents a validated method for assessing functional 
capacity from a carefully obtained history. Thii method repre- 
sents an important aspect of evaluating overall cardiac risk and 
planning appropriate preoperative testing. 
Table 3 strati&s the risk of various types of noncardiac 
surgical procedures. This risk stratification is based on several 
reported studies.lZ15J1Ja*8-M It is clear that major emergent 
operations in the elderly, ie, those violating a visceral cavity 
and those likely to be accompanied by major bleedii or fluid 
ShLFts, place patients at highest risk. Vascular procedures 
appear particularty risky, and, primarily because of the liketi- 
hood of associated coronary disease, justify careful preopera- 
tive screening for myocardiai ischemia in many instances. This 
aspect of decision making is covered more extensively in 
section IV. 
Climb a flight of stairs ot walk up a hill? 
Walkottlevelgrmmdat4mphor6.4km/h? 
Rtmaahmtdiaxmux? 
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Fig 1 (see Executive Summary) presents in algorithmic form 
a framework for determining which patients are candidates for 
cardiac testing. For clarity, categories have been established as 
black and white, but it is recognized that individual patient 
problems occur in shades of gray. The clinician must consider 
several interacting variables and give them appropriate weight. 
Furthermore, there are no adequate controUed or randomized 
clinical trials to help define the process. Thus, collected 
observational data and expert opinion form the basis of the 
proposed algorithm. 
Step 1 (FII 1). The consultant should determine the urgency 
of noncardiac surgety. In many instanca patient or surgery- 
specilic factors dictate an obvious strategy (ie, immediate 
surge& that may not allow for further cardiac assessment or 
treatment. In such cases, the consultant may function best by 
providing recommendations for perioperative medical man- 
agement and surveillance. Selected postoperative risk stmtifi- 
cation is often appropriate in patients with elevated risk for 
long-term auonary events who have- never had such an assess- 
ment before. This is usually initiated after the patient has 
recovered from blood loss, deconditiorti~, and other postop 
erative complicati that might confound interpretation of 
tmimsive test reds. 
Step 2 (Fig 1). Has the patient undergone coronary revas- 
cularization in the past 5 years? If the patient has had 
complete surgical revascularization in the past 5 yeam or 
coronary angioplasty from 6 months to 5 years ago, and if hi 
or her clinical status has remained stable without recurrent 
signs or symptoms of ischemia in the interim, the likelii 
of perioperative cardiac death or MI is extremely low.“r 
Further cardiac testing in this circumstance is generally not 
necessary. 
Step 3 (Fig 1). Has the patient undergone a coronary 
evaluation in the past 2 years? If an indiiidual has under- 
gone extensive coronary evaluation with either noninvasive 
or invasive techniques within 2 years and if the findings 
indite that coronary risk has been adequately amessed 
with favorable lindings, repeat testing is usually unnecessary. 
Art exception to this rule is the patient who has experienced 
?. definite change or new symptoms of coronary ischemia 
mce the prior coronary evaluation. 
Step 4 (Fii 1). Does the patient have one of the unstable 
amnary syndromes or major dinical predictors of risk 
(Table l)? In patients being considered for eIective noncar- 
disc surgery, the presence of utWable wmnary d&ease, or 
decompensated CHF, hemo+ramic&y sif@cant anhyth- 
mias,and/orseverevalv&rheartdiseaseusuabyleadsto 
cancellationordelayofsurgeryuntilthecardiacproblem 
hasbeen&ifiedandapprqniatelytreated.Exam*of 
unsWecoronqsjodnwesincl~etecentblIwithevi- 
denceofischemicrisk$&iciilqmptmnsorrm&va+e 
study,unstabk~sevt~arrgina,aod~Ol&COtl- 
trouedis4bka~cHF.Manypatiegaiothese 
1 hbIe 3. Cardiac Risk’ Stratification for Noncardiac Surgical 
I ‘rocedures 
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circumstances are referred for coronary angiography to 
further assess therapeutic options. 
Step 5 (Fig 1). Does the patient have intenne&e cliniral 
p&crors of risk (Table l)? The presence or absence of 
angina pectoris, prior MI by history or ECG, compensated 
or prior CHF, or diabetes mellitus helps to further sttiatilj 
clii risk for perioperative coronary events For patients 
with or without these intermediate chnical risk predictor 
consideration ofjiuhmd capacity (as determined by hii 
toryofdailyactivities)andlevelof5urgqsgeo~fcallotvs 
arationnlapproa&toidentifyingwhichpatientstttaymost 
benefit from further nonim&ve testing. 
Functional status has been shown to be a reliable predictor 
of future cardiac events3r If the patient has not had a recent 
txen5setes&thiscanusuauybEestimatedfromthe~tyto 
performtbeactivitiesofdaiIylivingF~~can 
beexFmsedinmetaboIic~t(M~kveb;the 
oaygenconsuqion(YO~ofa7C+4O-year-oIdmanina 
resting state is 3.5 ml& per minute or I MET. For this 
purpose,functiicapacityhacbeencknihcdasacellmr 
(greaterthan7METs),mo&mte(4to7METs),poor(less 
than4METs),orun&rmvR MultipIesoftheba5euneMET 
vahmcanbeusedtoexptessaembicdemamisforspeci6c 
activit&andtheuseoftheMETlevelisamoremeaningful 
andusefldt?xgJmhd exeee!~than~to 
eapresfia3ctional~ioterlnsofpotocdtimeandstttges 
reachedduring~enacise-Ille~pediatdlevelfa 
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mph. Activities that require more than 4 METS include mod- 
erate cycling, climbing ‘hills, ice skating, roller blading, skiing, 
singles tennis, and jogging The Duke Activity Status Index 
(Table 2) cm~tains questions that can be used to estimate the 
patient’s functional capacity.l,3’ Use of the Duke Activity 
Status Index or other activity scales” and knowledge of the 
MIS levels required for ‘physical activities, as listed above, 
pvide the dbician with a rekitively easy set of questions to 
estimate whether a patient’s functional capacity will be less 
than or wr than 4 METS (Table 2). A clinical question- 
naire, howe&, on!yesainnies timctional capacity and does not 
provide as objectiie a measurement as exercise treadmill 
testing or m ergornetry. 
Sorgery-Spdie Risk (%bIe 3, Fig 1): The surgery-specific 
cardiac fisk of noncardiac surgery is related to two impor- 
tant factors. First, the type of surgery itself may identify a 
patient with a greater likelihood of underlying heart disease. 
Perhaps the best example is vascular surgery, in whiih under- 
lying CAD is present in a substantial portion of patients. The 
d aspect iS the &grtX Of k~iiit cardiac StiCSS 
assodatedwithwrgety-specific technique.s.cetiopetations 
may be associated with profound alterations in heart rate, 
blood press~, vascular volume, pain, bleeding, clotting ten- 
dencies, oxygenation, neurohumoral activation, and other per- 
mrbat&LTheintensityofthesecoronaIyandmyocaKW 
strm help determine the likelihond of perioperative cardiac 
events. l&s is partiahly evident in emergency surgery, where 
theriskofcardiaccompUcationsissubstantiaUyelevated 
Examples of nonca&c uugery and theii surgery-spe& 
riskaregivenbelow.Hi$rerswgeryspec@wdioc&k(eg, 
combined periopemtive Mi and/or death rate equal to or 
greater than 5%) is present in patients undergoing aortic 
surgery, peripheral vasmlat surgety, and anticipated prolonged 
surgicplprrladmarsociatedwithlargefluidshiftsar%r 
bloodlossinvdvingtIleahtanen,thoram,head,andnedL 
I-surgiurlrickpraceduresinctude~Orthope- 
diGaaduncomplicated~,head,neckandthomcic 
sltrgely.~~hldudecataractresection,denna- 
tdosicoperationsendoscopicprocedures,~~surgev 
(TabIe 3). Patients undergoing low-risk pl-ocedures do Ilot 
requirefurtherevaluation. 
StepQfEg1):Patientswithoutmajorbutwithintenne&ue 
predicto!sofGnicalri&(Table1)andwithmodeiateorex- 
ceuentfimetionalcapacitycangeneJauyondergointemlediate- 
r&surgezywithlittklikelihoodofperiopemtiwdeathorM1. 
Ontheotherhand,patientswithpoorftm&malcap&tyor 
thmewithacombinationofonlymoderatefum%nalcayadty 
ZUldhighH-dSltsurgery~oftenmnsideredforfurthertIOtl- 
i(lwde~lltisis~tmeforforts~ 
lvmormoreoftheaboveintermediatemarkers. 
!%p 7 (Fig 1). Noneardiac surgery is genmliy safe for 
patientswithminororm,dinicaip&iuorsofeli&ilrisk 
~F~~)~~~~~or~t~~~ 
(equaitoorgmaterthan4METs),mgar&asofsmgical 
type.Paientswithpuorhmukmal~faciog~r- 
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risk operations (vascular, anticipated long and complicated 
thoracic,;abdominal, and head and neck) may be considered 
fdr further testing on an individual basis. 
To reiterate, it is important to emphasize that the concept of 
“medical clearance” for surgery is short-sighted. The real 
issue is to perform an evaluation of the patient’s current 
medical status, make recommendaticns concerning the risk 
of a cardiac problem over the entire pezioperative and 
postoperative period, and provide a clinical risk profile that 
the patient, anesrhesiologist, and surgeon can use to make 
management decisions. The overall goal of cardiac assess- 
ment should be a consideration of both the impending 
surge9 and, more important, the long-term cardiac risk, 
independent of the decision to go to surgery.j5 It is almost 
never appropriate to recommend coronary bypass surgery or 
other invasive interventions such as coronary angioplasty 
that would not otherwise be indicated in an effort to reduce 
the risk of noncardiac surgery. 
Step 8. The results of noninvasive testing can then be used to 
derermine further perioperative ma,iagement. Such man- 
agement may include intensified medical therapy or cardiac 
catheterization, which may lead to coronary revasculariza- 
tion or potentially cancellation or delay of the elective 
noncardiac operation. Alternatively, results of the noninva- 
sive test may lead to a recommendation to proceed directly 
with su:gery (Fig 1). In some patients, the risk of coronary 
angioplasty or corrective cardiac surgery may approach or 
even exceed the risk of the proposed noncardiac surgery. In 
rare instances, this approach may be appropriate, however, 
if it also significantly improves the patient’s long-term 
prognosis (Table 4). 
III. Disease-Specific Approaches 
Coronary Artery Disease 
Plmntsw&KnowncoroAorp~Disrrrse 
In some patients, the presence of coronary disease may be 
obvim such as an acute Ml, bypacs grafting coronary angio- 
plasty. or a coronary angiogram showing luminal irregularitifi. 
On the other hand, many patients without cardiac symptoms 
may have severe doable- or triple-vessel dii that is not 
cl&aUyobviousbecausethepatientsarefunctionallylhnitedby 
were arhitis or peripheral vascular disease. &h patients may 
benefit from non&a&e testing (Fig 1; Table 3) for d+nosis if 
the patient is a candidate for myocudii revasarlaritation. In 
petientswithlrnownCAD,asweUasthosewithpreviously~t 
comnaty~,the~bealme(1)whatisthearnoontof 
nlyocanliuminjeop&y?(2)Whatisthekche&cthre+o&ie, 
theamoWofstressrequiredtoproducei&emia?and(3)What 
isthepatients~hmdion?~tkalof~ques- 
tiobskanimponaolgoaIofllle preoperativehistory,physical . . 
~andse~nonimrasive te5tbgllsdto- 
thepatieot'S~grsdiemOfischemic~dlUiltg 
stress pbIe5).chldteotkerhar@manypl3tiemdooot 
reqoire-~~if~areootcamtidates 
formyom&irev;raartam9bon. 
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-P- stmr--* 
‘*bvancedap 
Funcbmal lapamy 
Eg 1. sepwise ipprd to fn-eqmative ediae nt. Steps are diiuzd in text. ‘ant care ma! include cat&latiwor dtlly of 
surgery, a~mnarj,revas~~lari7.atbn folbwcd hy noncardii swgety, or intemifkd care. 
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‘@We 4. Indieatiuns for Corontuy Angiography* in Perioperative Evaluation Before (or After) Noncardiac Surgery 
classIt:Patimtswttbsappededorp-cAD: 
s High-d& results during noninvasim testhag (Tables 6-9) 
. Angiaa peaoris ualespo~ to adequate tnedkal therapy 
. MOM patieats with unstable angina peclulis 
. Noadis@ or equivocal wnipvasive test in a high-risk Patient (Table 1) undergoing a k&h risk noncardiac surgical procedure (Table 3) 
ClassLIt: 
l latermediate&rearltsdudng mminvmiie mhlg (Tables 69) 
0 Nklm@mkorequivoeal aoninvasive test in a tower-risk @eat (Table i) undergoing a high-risk noncardiac surgical procedure (Table 3) 
. urgeM-noneardiac ArgeTy in a patient comalescing from acute MI 
0 PerioperativeMI 
classuIt: 
a Low-risk noncardiac mugery (Table 3) in a patient with known CAD 3rd &-risk msnlts on noninvasive testing (Tables 69) 
e smewiag for CAD witbout appropriate noninvssive tSing 
l Asymptoroatk after coronary revas&arhation, rvith excellent exercise capacity (27 METS) 
l Mild stable an@na in patients with good LV function, low-risk nooinvasive test results (Tables 69) 
a Patient is not a candidate for wronaq mvam&imtion becanse of conwmitant m&al irlnem 
l Rior twbnically mleyate mxmal comnmy aogiogram within 5 years 
a Severe LV dysfa&on (eg, ejection fraction ~20%) and patient not considered candidate for revascularization prcced.re 
l Patient unwilling to wtmider coronary revazmdariration Procedure 
*If resnlts wih a&et nmnagement. 
tch%I: Cond&ns for which there ls evidence for and/or general agreement that a procedure be performed or a treatment is of benefit. Clam 11: Conditions for 
which there h a divergence of evidence and/or o@don abnnt the treatment class 111: Conditions for which there is evidence and/or general agreement that the 
pmwdQreisnutnecesnmy. 
cADiadfcates eomnarv artery W MI, mvogldial i&r&on; MFT, metabolic equivalent; LV, left ventricular. 
Table 5. F’mgnostic Gradient of Ischemic Responses During an 
ECG-Monitored Eszrcise Test* 
Isebemis indud by low-level exerciset (~4 MET’s or heart rate <lOtI bpm 
or <7C% age predii) manifested by one or mom of the following: 
l Horirontal or dotmuloping ST &pm&on X3.1 mV 
l ST-segment elevation 20.1 mV in noninfarct lead 
l Fiiormre*uoosIlesds 
. Per&en1 hehemic reqmnse >3 min after eaertion 
0 Typicaangina 
IntereKdiateRlsk 
~indueedbymodenteleveteXe~'(66h~SMheart~le1uO130 
bpm[7O@%agePredieq)manifenedbymteormoreofthef~ 
l Horimtal or dcmdopiag ST depmsii Sl.1 mV 
. Ty~icalangitta 
l Persistent ischemie respmme >l-3 mitt after exertion 
l Tbree10fonrabmnmalloads 
LawRisk 
No ischda or imhemia indnced at high-level eaerdse’ (>7 METS or heart 
rate >130 bpm [X75% age Pmdict&)) manifested by. 
l Horimmalordovmsloping!Sdepremionjo.1 mV 
l Typicalaagina 
l onetowsbnmmalk4ds 
laamte Test 
bmbihtytorea&adeqnamtargetworkmadorheartraterespmueforage 
&hotttimiS&mii~.F~patiensundergoingMm?lrdiaCswgety, 
mtermediate-rishlcvelwitltmaisehemia 
i?kizlLzkaatbe. atlowrhkforperiqrativehdtemicevents. 
EcGiadiwtweiecboovdmgrapbieagy,,~equiralen$bpm, 
bwtsperxtiimle 
‘bedoorefawoes3237-43. 
twortbsdsQdheartrateatisrrteskKrt6ksevedty~llire for 
mirpc. targetheartralesfar~aad~~ 
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Peripheral vascular disease presents a special problem 
because it is associated with a higher incidence of CAD and 
because the limited acrivity imposed by daudication may mask 
coronary disease. A full discussion of the implications of 
peripheral vascular disease can be found in section IV. 
Hjpertension 
Numerous studieW5J~r-Q~2 have shown that moderate 
hypertension is not an independent risk factor for periopera- 
tivs cardiovascular complications. 00 the other hand, as a 
universally measureJ variable with a recognized asscciation 
with CAD, hypertension serves as a useful marker for potential 
CYID.~~ In addition, several investigators have demonstrated 
exaggerated intraoperative blood pressure thtctuation with 
associated ECG evidence of myocardial ischemia in patients 
with preoperative blood pressure elevation.~s7 This effect can 
be modified by treatment5~ Smce intmoperative ischemia 
correlates with postoperative cardiac mo&dity,5r*r it follow 
that control of blond pressure preoperaSvety may help reduce 
the tendency to perioperative ischemia. Although an elevated 
blood pressure on an initial recording iu a patient with 
previously undiagnosed or untreated hypertension has been 
show0 to correlate with blood pressure labihty under anesthe- 
siap* the definition of the severity of hypertension rests with 
subsequent recordings in a noustressful e.nvironment.53 In 
patients on therapy for hypertension, a careful review of 
aurent medications and dosage, along with known intolerance 
to previousfy prescribed drugs, is essentiaf. ‘the physical exam- 
ination should include a search for target organ damage and 
evidence of awciated cardiovascular pathology. In pat&&u, 
a funduscopic examination may provide usefuf data regarding 
the severity and cbromcity of hypertension. 
The physical examination and simpie laboratory tests can 
rule out some of the rare but important causes of hypertension. 
Further evahmtion to exclude secondary hypertension IS rarely 
warranted before necessary surgery, but in patients with severe 
hypertension, particularly Of tc;Leni OnSet, it may be appropri- 
ate to delay elective surgery whii the patient is evaluated for 
curable causes of hyperteusion. If pheochromocytoma is a 
serious posibdity, surgery should be delayed to permit its 
exchtsion. A long abdominal bruit may suggest renal artery 
stenosis A radial to femoral artery pulse delay suggests 
coarctationoftheaorta;hypok&miaintheabsenceof 
diuretic therapy raises the possii of aldosteronism 
If the initial evahiation estabbb hypertensiou as mild or 
moderateandtherearenoassoc&dmetaboticoroudkwas 
CUhZlbtlO~the~iSllOdtO&hySlUg~.~seWd 
investigators have e&bWed tbe value of effectitie preopera- 
tive.bloodpresurecontro&~7~@@andan~ensivemed- 
icatiom should be contiuued during the periopetative period. 
Pa&ularcamshouldbetakentoavoidwiMmwalof~ 
blockemauddonidiae~ofpotentialheartrateandlor 
bloodpreswerebo&.iopatientsunabktotakead 
medieaw patenteral f3aodLers and traBs&tmai dooidine 
may&d 
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If more severe hypertension (eg, diastolic blood pressure 
greater than or equal to 110 mm Hg} exists before elecbie 
noncardiac surgery, it is prudent to control it before surgery. In 
many such instances, establishment of an effective regimen can 
be achieved over several days to weeks of preoperative outpa- 
tient treatment. If surgery is more urgent, rapid-acting agents 
can be administered that allow effective control in a matter of 
minutes or hours. @-blockers appear to be particularly attrac- 
tive agents. Several reports have shown that introduction of 
preoperative @drenergic blockers leads to effective moduia~ 
tion of severe blood pressure fluctuations and a reduction in 
the number and duration of perioperative coronary ischemic 
episodes.S5-60 
Interestingly, patients with preoperative hypertension ap- 
pear more likely to develop Waoperative hypotension than 
nonhypertensive persons In some patients this may be related 
to a decrease in vascular volume. In one report, hypotension 
durieg anesthesia correlated better with perioperative cardiac 
and renal complications than intraoperative hypertension, 
although other studies hdve not shown thiss7 
Congestive Heart Failure 
Congcdve heart failure has been identiged in sevetal 
studiesasbemgassociatedwithapooreroutcomewben 
no- surgery is performed. In Goidmads study>* the 
preseuce of a third heart sound or signs of CHF were 
associatedwithasubstant.iallyincreasedriskduringnoncardiac 
surgery. Detskyn identihed afveobu pulmonary edema as a 
significant risk factor, and in cooperman’s ~p~q*4 cHF ak0 
bestmvedasign&antrisk.Everyeffortmustbemadetodetect 
mwspec&heartfaifumbyacarefulhistoryandphysi& 
examination.ffpo&le,itis@ortanttoidentifytheetiology 
ofCHF,becausethismaybaveimpbcationscomxrningriskof 
death versus petioperative CHF. For instana, prior CHF due 
to hypertensive heart disease may portend a different risk 
compared with prior heart faihue resulting ftom CAD. 
caniiomyopnthy 
lliereislittleiuf~ onthepreopemtiveduatialof 
patients with cardiwnyopathy before tummud& surgery. At 
this*preopaativereamnneadprnmntwtbebasedona 
undcrstmdingofthe~ofthe~ 
tIiXXeSEVenre;rpoo9bte&dtmlkJbernadebcRxe~to 
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&reasedvenouscapacitancemaycauseareducdoninleft 
ventrkadar v&me and thereby potentially increase a tendency to 
obsmdon with potentially untoward results Further- 
more, reduced tilling pressures may result in a signilicant fall in 
stroke v&me because of the decmaxd compliance of the 
IyprtqW ventricIe. Cam shot&J be avoided be- 
CmIsetheymayinaease thedegreeofdynamicohs@uctionand 
decream diastolic IiIling In a relatively small series of 35 patients 
witJ~ hypeqhk cardiomyopathy with obstruction there were 
no deaths or se&us ventricular arrhythmias during or immedi- 
ately after gemal surgkal procedu~ one patient had major 
vasadar surgery. In the 22 patients who underwent catheteti- 
tion, the mean rest and peak provokable gradiints were 30 mm 
EIg and 81 mm H& respectively. The only patient suffering a 
periuperative MI had twc-v-1 coronary disease. Siguihcant 
adythmh or hypotenskm requiring vasocotiots arurred 
in 14% and 13% of patients respecuvely.~ Patients with hyper- 
tmphic cardiomyopathy are also at an increased rirk for periop 
eratk CHF. 
Vhhdar Heart Disease 
Cardiac murmum are common in patients facing noncardii 
surgery.Thecons&mtmustbeabletodistinguishorganicfrom 
fimctkm~.sig&amtfromiosignificant,andtheetiologyofthe 
mmmurinonSertodetennlnewhiipatientsrequireprophylaxis 
‘for endocarditis and which patients require further quantitation 
oftheseverhyofthevalvularlesion. 
Severe aortic stenosis poses the greatest risk for noncardiac 
surgery.:2Iftheaorticstenosisissevereandsymptomati$eleaive 
rmncardiacsurgeryshouldgenerallybe~monceled. 
!SUCII pthts require aortic valve rqhxment before elective but 
0~noneardiacsurgery.Inraminsrancegpercutaneons 
haIloonaortics&uh@s&maybejustihedwhenthepatientk 
notaca&Iateforvalvere@acement. 
Mii stenos~ ahhough increasingly rare, is important to 
recognize. When stenosis is mild or moderate, the cons&ant 
must ensure coutrol of heart rate during the operative and 
perioperative period because the redttction in diastolim filling 
period that acoompanies tadaycardia can lead to severe put- 
monary mmg@ion. When the stenosis is severe, the patient 
ltUy betk&t from balloon mitral valvuloplasty or open surgical 
repair before high&k stugery?* 
Aortic regurgitation needs to he identifmd, not only for 
appropriate ptophylaKis for bacterial endocarditis, but also to 
ensure appropriate medii treatment. Careful attention to 
volume cuntnd and aftehad reduction is recommended. In 
amtmstto0~sevemawticregurgitatjorlisnot 
beoefitedby~slowhearrateawIticllcan~the . . 
~byincreasiilgtheammmtoftimein 
~.~~ pikduminantly afFeets CliaFtole and thus 
E?xlasthetimeaf~inswereaortjc~ 
mraIregurgitationhasmalyc;lmes,themostcommoo 
~~~l~~~~rnj~~~. 
PerIoperative antibiotic pmphyh& ls reammended for pa- 
~~~~~~b~e’~rn~~~- 
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diographic evidence of mitral valve regurgitation or thickening 
and/or redundancy of the valve leafletsi Since perioperative 
volume shifts may cause a patient with an isolated click to 
devc iop mitral regurgitation, auscultation in the sitting, stand- 
ing, squatting, and standing-post-squatting positions may iden- 
tify a tendency to volume or stress-related regurgitation. 
Patients with severe mitral regurgitation (often manifested 
clinically by an apical holosystolic murmur, a third heart sound, 
and a diastolic flow rumble) benefit from afterload reduction 
and administration of diuretics to produce maximal hemody- 
namic stabilization before high-risk surgery. Occasionally this 
therapy can best be accomplished by treatment in an intensive 
care unit using a catheter to monitor pulmonary artery pres- 
sure. It is also important for the consultant to note even mild 
reduction of left ventricular ejection fraction (LVEF) in pa- 
tients with mitral regurgitation. Because the low-pressure left 
atrium acts as a pressure runoff in patients with severe mitral 
regurgitation, LVEF may overestimate true left ventricular 
performance. In such patients, even a mildly reduced LVEF 
may be a sign of reduced ventricular reserve. 
Patients with a mechanical prosthetic valve are of concern 
because of the need for endocarditis prophylax9 when under- 
going surgery that may result in bacteremia and the need for 
careful anticoagulation management. The Fourth Gmsensus 
Conference on Anticoag&tion recommends the following+ 
For patients who require minimal invasive procedures (dental 
work superticial biopsies), we recommend brie@ reducing tbe 
INR to the low or subtberapeutic range, and resuming the 
normal dose of oral a&coagulation immediately following 
the procedure. Perioperative heparin therapy is recemmeruJed 
for patients in whom the risk of bleediig on oral auticoagula- 
tion is high and tbe risk of tbrombuembelism OR anticoaguta- 
tien is also bii (major surgery in tbe setting of mitral valve 
prosthesis). For patients between these hvo extremes, pbysi- 
ciam must assess the risk and benefit of reduced anticoagula- 
tion versus perioperative heparin therapy. 
Arrhythmias and Conduction Defects 
Cardiac arrhythmias and conduction disturbances are com- 
mon findmgs in the perioperative period,izi6”7 particularly in 
the elderly. Although both supraventricular and ventricular 
arrhythmias have been identhied as independent risk factors 
for ccronary events in the p&operative peri0d,~~7 they are 
probably signilicant only in that they either reflect or occur in 
the presence of underlying serious cardiopuImonary disease 
whii by itself, increases the risk of surgety.M The presence of 
an arrh@mii in the perioperative setting should provoke a 
thorough search for underlying cardiipuhnonary disease, drug 
toxicity, or metabolic derangements. 
Many cardiac arrhythmias, although reIativeIy benign, may 
umnasktmde#ngcardklcpnoblems;farerample,supraventric- 
UkUildlphkCUIproduct:Gehemiaby~myocardial 
axygendewmdin~withcomnmydisease.Rarety,, 
mia%heotuseofthehemodyllamiormetabolic 
theycaus%may-intonmrelife 
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disturbances; for example, atriaf fibrillation with a rapid venbic- 
ular rtspnse in a patient with an w bypass pathway may 
degenerate into vennicufar fibriflation. Ventricular arrh@mias, 
whether single premature ventricular contm complex ven- 
tricularcctopy,ornom&a&dventricukuta&ycardiiusuaUydo 
notrequirethe~exceptiJlthepresenceofongoingorthreat- 
enedmyoc&afbchemiaormoderatetoseverck.ftventricuku 
isfikelythatsucharrhythmiashavethesamebenignprognc& 
pekperatively as that demon&d in fx@atkm studiesB.m 
High-grade cardiac conduction abnotmahties, such as com- 
plete atrioventricular block, if unanticipated can increase 
operative risk and necessitate temporary of permanent ttans- 
venous pacing. On the other hand, patients with intraventric- 
ufar conduction delays and no history of advanced heart block 
or symptoms rarefy progress to complete heart block pe+p- 
eratively7r The availability of transthoracic pacing units makes 
the decisiin for temporary transvenous pacing less critical. 
pulmonary Vic&r Disease 
lherearewllqmedstudiesthatspecatcailyassessthe 
aticstudiesoftberiskofnomx&acsurgcryforpatiemswitb 
surgeryforcongenitalheartdkease.Fnreycarsaftcrsurgetyfor 
ventriadar septaf defect or patent ductus atteriaay pulmonary 
vasoreaalvityoftenremainsabmmnal,&masingtohighfevek 
Patients with congenital heart disease have ako demon- 
strated a reduced cardiac reserve during exercise.73 Postoper- 
ative studies of patients with coarctation of the aorta or 
tetrafogy of Faffot have demonstrated fittdmgs consistent with 
tmdedying impairment of ventricufar function.74~~ These ob 
servations should be kept in mind when evahrating such 
patients before noncardmc surgery. Patients receiving primary 
cardiac repair at a younger age in the present era may be fess 
prone to postoperative ventricular dysfunction because of 
improved slrgid techtlii~ 
whiimostexpertsagreethatptlkmmy~pertemiooposes 
anincrea&riskfor~surgery,noorgammdstudyof 
theprobkmhasbeenperformed.~orltyanalogorssltoatialk 
faboranddeliwxryforsvDmeawhh~rsymhomeduet0 
atxmge&li@acm&cshunt.Periparhunmmtahtywaste- 
portedtobcbatwcen3o%and7ft%inlWl,hutnorcccntdata 
exkttoc&rifywornotthkhasfaBenwitJl~~in 
care.~Inpatkntswithscverepuhmmmybypertmukntamfa 
cardiaccshlmfhypotehypotelaiooreauhshincreasedrightto 
left.dmltingand~the~todevelopnentof 
t3CidO&WhiChCaOleadt0hirtherdcaeas*,iOsystnnicMpa;ltar 
re&ancelltisrydcmustbemcogni&artdappopiatdy 
lteatd’ 
hwwv 
IV. Type of Surgery 
In a recent review- Mangano’ deterinined that cardiac 
complications are two to five times more likely to occur with 
emergency surgical procedures than with ekctrve operations. 
This finding is not surprising since the necessity for immediite 
surgical intervention may make it impossiite to evaluate and 
treat such patients optimally. For instance, collected data have 
confbmed that the composim mortality rate for elective repair 
of patients with arymptomatic abdominal aorttc aneur~zms is 
signitantly tower (358) than that for ruptured aneuryxms 
(42%)” The mortality rate for graft replacement of symptom- 
atic but intact abdominal aortic aneurysms rzmnins relatively 
high (19%) despite the fact that, like elective cases. they are 
not associated with antecedent bfood loss or hypotension. 
Unfortunately, most true surgical emergencies (eg. symptom- 
atic abdominal aortic aneurysms perforated v&us, major 
trauma) do not permit more than a cursory card&c evahration. 
In adottion, some situations do not tend them&es to 
comprehensive c&ii evaluation. ahhough surgical care may 
qualify as semielective. In some patients the impendiy danger 
of the d&ease is greater than the anticipated perioperative risk. 
Exampb inch& patients who require arterial bypass proce- 
duresforfiisdvageormemmenc~toprevent 
intestinal~.Patientswithmalignantneopbsmasopose 
adiagno&andtbcraprutictbkmmawahrespadtopmopem- 
tivecardiaf~~,whenitis~todaermine 
vels&~~~kaoaMehefore~~ 
satuadm~theimportanoeof~ 
umtm~amoug-ssurgeoRand~ 
toplananafgxoa&forcardioc amczmcntthatisappopiatefor 
theidividdpatjentandtheunderlyntgdisease. 
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&at peiiqeral& czadac morbidity is particularIy concentla*~ 
amollgpetientsWbOUndergOmaprthoracic,awoniinaLOr 
vmnJarsurgly,~wtKntheyare7Oyearsordd 
a>.- As&on et aP prmpdvely studied the incidence Of 
perioperativeMI~witbtho~abdominal,urdogie, 
~andvascularsurgeryinacohortof14#menoider 
than 40. ne highest idaruiml rate (4.1%) (odds ratio, ‘1039 
%%c3nMenceintenal[q23to475)oawredintheslbset 
d*ntsWitbiUIestablisbeddiagnosisOfCAD.Nerertklesr, 
mdepe&msi;;liticamriskfaetorsformfamtkmakoimhtded 
agegreaterthan75years(oddsm~4.n:%%:,1.17to19.41), 
mdtheneedfure-kaive~surgerywenintbeabsenced 
suspeaedCAD(~odQmtio,3.n:%tCI,l.l2tolU7). 
Few pmcedureqeeific data are available regarding periop 
t=ralkcardiae~inmostsurgkaIspeciahiesperhapa 
because~ageandserious,ineidelltalcADared 
tobedistriitedraadomlywithingroupsofpatKntswiloundelgo 
Ilcmadii opera- iJl such fiekis as germi surgery, thoracic 
surgery,0rtlqdburdogy,gyoeodogy~~aadneurosurgery. kd- 
ersenetaPfotmdbyiogi&regmaGnthatagegreaterthiulor 
equaito7Oyear5MIwitbintheprec&lg12monthSandcHF 
weret3timadwithaninaeasedineiderceofpostoperative 
cardiaccomphcationsinaseriesof73JBpatierttswhounderwent 
amixofboth”mapr”and”miaoSgastminte&nai.urok@e 
~Bop~pmcehms*~~~apu~ 
amehmemtnamucbsmafiersertesof52paWntswfm 
remriredekcuvehipartt8opbsty,the11frauemsinthisstudy 
w4luhadplxvimseliniadiodicatiomdcA.Dslrrtained~ 
can~higilerratesof-ischemiaorMldmirlgthe 
~period(~odrkm~,l.e,%%C/0.7to52) 
andiateeardiaceventsdming4yeamoffoBow-up(adjt&dodds 
ratio35;%%~,13io9~)thandidtheremaining41pluients. 
As shown by Ashton et airs and many othefs, however, 
patients who require vasadar surgery appear to have an 
irlcm?driskforcardiaeeom~- 
l Mzryoftberiskbtctorsamuibutmgtoperipheral 
vascular disease (eg. diabetes meIli;us tobacco use, 
hyperlipidemia)areakoriakfaetorsforcAD. 
* TRe UsuaI syrrytomatic presentation for CAD in these 
l Majorrdelialoperatinosoftenaretimeawsumingaod 
maybeassoeiatedwitbsubstantialfluchIation5inintra- 
-~vdulaes-~F-yy 
temicbIaKIprrzme,beartratr;andthmarbo%enmy 
T@oreeentstudiihaveattempted tostratifytheincidence 
of periopemtive and intermediate-tetm Ml acanding to tbe 
tigirmitypeofvaseukusurgeryperformed.Inapmspe&e 
aetieaof53amtiepro&umsartd87iu~bypass 
gdtSkUWhiChogerativemortaiirjrates~~nearfyiC&IltiCd 
(9%aud7%,rq.le&efy),KrugnkietaN5fomtdtbattberiak 
forfaWmmfatalMIwitbina2-yearfoUow-upperiodwm35 
timeahigher(21%wXmta65&)amongpatienbwboreceived 
**-PnJbJ%i--d 
mefittm (44% versus 11%) ad a 
ofptm6ousMI(43%wXWa2&%), 
l5%),orcxF(29%-9%)alsoweI 
prevalent in the infrainguinai bypass group. L’italien et al* 
have preserted comparable data regarding the perioperative 
incidence of fatal/nonfatal MI and the dyear a*en!-free sur- 
vival rate following 321 aortic procedures. 177 infrainguinal 
bypass grafts. and 49 carotrd endarterectomies. Slight differ- 
ences in the overall incidence of MI among tbe three surgical 
groups. which may have been related to the prevalence of 
dia’ :tes meiiitus, were exceeded ahnost entirely in significance 
by the influence of discrete cardiac risk factors (previous MI, 
angina, CHF. tixed or reversible thallium defects. ST-T depres- 
sion during stress testing).W These and other studiesS suggest 
that the clinical evidence of CAD in a patient who has 
peripheral vascular disease appears to be a better predictor of 
subsequent cardiac events than the particular type of periph- 
eral vascular operation to be performed. 
In a selective review of several thousand vascular surgical 
procedures (carotid endarterectomy. aortic aneurysm resec- 
tion, lower extremity revascuiarization) reported in the English 
literature from 1970 to 1987, Hertree found that cardiac 
compiiitions were responsible for about half of ail perioper- 
ative deaths, and that fatal events were neariy five times more 
likeiy to occur in the presence of standard preoperative 
indications of CAD. Furthermore, tbe late (S-year) mortality 
rate for patients who were suspected to have CAD was twice 
that for patients who were not (approximately 40% versus 
20%). Ii is notewortby that both the pertoperative and S-year 
mortahty rates for the smaii groups of patients wbo previousiy 
had coronary bypass surgery were similar to the results re- 
ported for larger series of patients who had no clinical indica- 
tions of CAD at tbe time of peripheral vascular surgery. 
Published mortality rates from large referral centers may 
not reBect the results at thousands of other hospitals througb- 
out the United States in which, coiiectiveiy, most vascular 
sugpies are performed on an indiiduai, tow-volume baGs 
Hsia et aig have cakuiated that fewer than 10 carotid endar- 
terectomies were performed an. naiiy at 45% of ail hospitals in 
which Medicare be&ciaries received this procedure from 
19t35 to 1989, and Fisher et al* demonstrated that the periop- 
erative mortality rate (1.1% to 3.2%) had an inverse relation to 
the low volume of earotid ettdarterectomies rn 2tJ?+9 Medicare 
patients at 139 New England bospitais. Simdar trends @gh 
vobmdow risk, low vohune~gh risk) have been continned by 
statewide audits of aortic aneurysm resection in Vermont. 
Kentucky, and New York.IR9r In New York, for example. 
Hamtan et aP reviewed 3570 ctec+~, aneurysm resections 
from 1985 to 19Vand found a linear, inverse relation between 
case voitmte and mortality rates for surgeons Go annually 
petfomled two or fewer operations (11% mmtabty). three to 
nineopemuom(73%mort&y),or1ttormoreoperattotu(5.o% 
mortaMy).Nocompau&dataareavaiWefmiowerextremity 
bypampmc&ma,butacamkngtotbeNatiooaiCenterfor 
HeaIthst2htiqthepotentialmagr61udeofthisprobIemis 
iIIismdbytheErttImteadlyearapproxima(eIy1ooollo 
fromUSfmspkakafter~ex&emby 
CItamiuetaP~coBeuedl9%tdatafatbe30mosteommott 
were st&dled 
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from nearly 5 @JO 000 admissions to over 5000 bospitals. Of48 
homogeneous medical and surgical conditions developed from 
a statistical model. only four had adjusted mortality rates that 
clearly could be correlated from one condition to another. 
three (carotid endarterkaomy. aortic reconstruction. lower 
extremity revascularization) involved vascular surgery, ar.d the 
fourth (total hip repkement), orthopedic surgery. Thus, if a 
hospital did well or txxniy with one of these operati it 
tended lo do equally well or poorly with the rest of them. 
Considering the fact that the prevalence of CAD contributes 
substantiaIly to the perioperative risk of vascular surgery, at 
least Salk: of the differences in surgical outcome from one 
hospital to another may be accounted for by variations in the 
degree to which it is recognized and appropriately treated. The 
level of this awareness aIso has impkations regarding late 
survkd. In the prospe-ctively randomii Veterans Admink- 
tration trial of carotid endarterectomy versus nonaperative 
management for asymptomatic carotid stenosis, for example, 
morethan2O%ofbothmndomiAcohortsdiifromcardiac- 
related compliitions within a follow-up period of 4 years% 
AsFleiiand8arash95have~~edthf!spedftc~ 
calsettingmustbeakderedwitbinanya@ithmregard& 
preopprativecardiacevaluation.-Ilietermnrnrrmikrr~is 
e?roeodingtybroafIinitsde~it~8giagpatientswim 
compleKtechnicalprdIletns8swellasyoungerpaiieols- 
IorstraightfonvardsurgicalpoceduresAs&se4aedaboue, 
-morbidity8nd~notodyv8ry8moug 
pl‘cmhshntamong- forthesameprWedWe. 
lkrefore,inasseGngtkrkkrandbenefitsofa~ 
ilttervention~,*aprociatcdwith-surgery 
nmstbeindii1tsimportantto-,however. 
thattheindkaksforfflmnatyinterwntionsbaddmtbc 
redefinedsimplykauseapatientwbohasCADofmargiA 
s@kanceakohappenstorequireamajorrtoncmkpoct 
dure.~,the~implicatiagdsevereleftluain 
OrBipk-vesSeldise;seand-letiWntricuhrhtnon 
arenolesomincus fdlowingaminurnomxdbc~operarian 
theyareinanyotherpatient.IntheIinalan+konedthe 
dtimateobje&rsdtbepeoperatkrecardiacassanoentkto 
exhldetheptk%ncecf~semurcADthatsmpformof 
diIectimerventionwotddbewarr8ntedcwnifm- 
operatimweretvasiuy.Inthisreg8td.tipnsartataafor 
nonc&acsurgetymaysimplyqxsentthefkttimethata 
ptietltwiIhoKrtorslispmedaKauryhcart~h8s8tl 
opportunity for m - 
In summary, the stugial procedures have been dassifted as 
low, intermediate. and high risk as shcwn in Table 3. Although 
CYXOMlydiseaseiqttte~nvhebnirrgrirlrfilCtCWfor~~- 
etivcmorbidity,proceduraddiferrntleKkdstrr%me&so- 
d8tedwithdi&rent~d~8nd~.slperfichl 
8nd~procedraesrrpeseDtthelowestrislc8ndgc 
ntrdy-with-~atidmatatity.Mspr 
Vasarta~~repaent~hibbesl-cislrpaeduerWIthhr 
theinewcdiarpriEL~,rrmtrirfitymIdantsliryvmy, 
nuiddrifalihle 
cbnrpatmdbg:tlftilt 
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heart rate crater than 75% of age-predied maximum can be 
expected in approximately half of patients who undergo tread- 
mill exe&, with supplemental arm ergometry when mxes- 
smy for patients limited by daudicatkm.lw The frequency of 
anahormdexerciseECGrespomebdeperKienton$nio? 
dinii history.~~~~~~ In patkrm without a cardiac history and 
a normal resting ECG. approximately XI% to 25% of patients 
wiUhaveanahnordexerckECG.lXefrquencyisgreater 
(3S%to5O%)inpatientswitbapriurhistqofM1oran 
abmrmalrestE(xi.IberiskofperkpmhcaKliaceventaalKi 
Li3qtemrisbisBignificantry~in~withanalmor- 
d ekapise m a loq# ~“‘“113 
v--W-f 
l3rmckr ‘85”’ 48 16 (33) 3 (6) 19% (306) lfNl% (35X) 
cl&f ‘81’” 116 54 (47) ll(10) 2lX(lll34) IO@% (@6OJ 
l+klcJlel ‘88” 67 15 (2) 3 (4) m&(3/15) lao% (5656) 
r+adswn 46 14(31) 2(4) 14% (Yi4) low (3l24) 
bg!eW’ 2lB 82 (411 15 VJ 16% (1382) 98% (6Mq 
McEmca 9o’B 95 34 066) 7 (71 9% (x34) %9 (4446) 
Ycarnk 90’2’ 111 ww 8 (7) 15% (WJ) im (51.51) 
h!fagamPi’~ 60 22 (3-0 3 (5) 5%&22) 951(1M) 
suam91* 68 da 4 (61 wa loopr (2121) 
WaneIs PI’” 26 15 m 3 (12) aI% (X15) lax (11,‘ll) 
FfeIukl92’” 327 167 (51) )? (9, 13c; a-1 XT 99% (97%) 
&tle 92’” 355 161(45) WI.1 :..$‘t, 99% (ibLy1621 
lAad.m 92” 65 45 (69) 5 (8) ii% (i45) iw (2wo) 
i3lwn 93” 231 n (33) 12 (5) 13% (wn) m (12w21) 
Icremik 93’s* IA) 67 (39) 5(3) 4% wq *s (-J 
I%cmn 9P 45-l l@(W WJ 4% (7/1f#) 96% U9sItm) 
-I* 
ElQ W’Y ?37 ilO(46) 17 VI 11% (12mO) lat% (m97J 
-wacrJlt 
CanQ -xi”5 u) 9(t3) 6W 61‘? (69) 160% am3) 
lqbai 9:‘s 31 II (41) 3(iO *n% (3’11) low (JUP) 
cdq -92’9 loo ww 4 (4) 8% m6) WI ww 
sii¶w 92” 60 B(47) 6U‘J) 21% (628) 1m (lV19) 
Taka3e 93’3 53 i5 (W 6(11) ,nx (1115) KWi (3332) 
Yamis W” 161 5u(3U 15 (9) ifJ% VW wx (8789) 
Rd-~a*,numberdp**ob*ho- ?ar@q?~~sperdbl~TE&lracrgLapr~~l~ 
qacardid~t,sndiEs~phrnsdobifa~arcirc~~ 
ABIluslescreptembyC’~~~‘~~~~~.~~~~~~~~~’~~~~ 
fromz3lmdiqpsddnr 
Raiamwitb6ra3ddearsrrreomitIaifm~dpdiKidrpliKpreddivcn*c 
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EVMS Predictive Valwt 
%enkwitb hfVDwb criteria for Ptitive/Ml or 
Aptbar n’ wemia (%) (W -Test Death Neptk Cwtmnk 
Lane 9l’G 38 50 3 (8%) NWWMA 
Lab %!‘a 60 50 9 (15%) New or worsening 
WMA 
Eichaqer%‘* 75 36 2 (3%) Neworamrscning 
WMA 
lagan ‘93” 74 24 3 (4%) NewwMAcs 
-changes 
pclbmak w= 131 27 5 (4%) Neworworseamg 
WMA 
Dhila Ron&l 93” 88 23 2 (294 Neworwotming 
WMA 
16%(3/19) 
23% (mo) 
7% (2q 
179 (3/18) 
14% (5135) 
IL% (x0) 
100% (19ii9) vasadar and general slrgery 
93% c?w3o) tshhiwia(em 
lam (48148) ManagingphysieiamtdindedtoDsE 
results 
Ial? (56/56) 
lc: ,i (96196) MldIivaria1e allal& managing 
physicim blinded IO DSE resnhs 
~~ ww lnclti long-term fd)orvup 
lrbmathn obtahed is aetkely used to select patients for The we ofdob&amhe stress e.chocadiogra~y in popemtive 
tlleqtentic itlte- suebasanvnaryrevaseu~tionas risk assessment was evaluated in sis studies, all published since 
weUastoadjustpe.Soperativeme&altreatmentandmord- 1991 and ident&ed by a computerized search of the English 
toring and to select different surgical pcedures. The negative language literature (Table 8).1”J47-‘s1 The populations in- 
predhiivalueofanormalscanremainsanifomdyhigbat eluded pdomimmtly. but not exeltiely, patients mdergohg 
appxhteely!B%forMfand/orcar~df!atk.~the pelipberal vascular 8wgical procedures= only twu titudks 
ri&ofa~~eventkl~tavdtbfba!ddefeus blindedtbepbysiciansm’d~wllotreatedtltep;ltients 
to tbe dobutamine stress echocaritim results’m.‘e In 
tberemainingstudkstberestdtswereusedtoiaftuenee 
lEenecdforcautkminrontinescreehgwithadipyrhm- preqeratiwmanagcmeri~parhhlytbedfxisionwketheror 
oktldimnstreastestofaupatieotsbeforevascularsurgery nottoproax45withawonarym&gmphyorwonatyteva.+ 
Intbisreviewof457 cukuiza~beforeekaivr:surgery.~studyusedshnilar, 
lnitnotidehc&proWokxTbedeIinitionofapositiveand 
agegreatertbm4Syeu5were negativetestrestdtdiffered~rably,basedon~ 
tbanperfusion riualy&of~waumotion;ie,wwseningof~ 
i-t3@3 WdlDKlth-waSCOllSideredbysOmeillV~- 
inseve&pobticatioosbyHer&let~*~Letteet~l~and torsasapitiveandbyothersasanegativehdirig.Theend 
tiollof!xanabnmma& pOht8USWJtOdefuKdiniraloutoaKVaribdand*~udedbOth 
ri&-ntand “soft” (ie. adythmii heart failure, and isdtemia) and “hard” 
thatasthesixof (ie,Mlorca?dIaedeath)m+ktllts. 
Thedataill&atetbatdobutaminestress 
canbeperfolmedsafelyaDd~~ 
lAcCVd27.No.4 
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wInJmadditiw;rl- ormedicaIinte~mig4tt!e 
notsupporttheuseof 
odydiagno&testto 
may be appropriate to 
pmyd w$tznary angiopphy rather than perform a 
example, preoperative consultation may 
umtableanginaorevidenceforresidual 
recent MI for whom coronary angiography 
is indicatfd. In genera& indications for preoperative coronary 
an&pphy are similar to those identified for the nonopera- 
tive setting Table 4 provides a summary of indications for 
rtive amnary aqbpphy in patients being evaluated 
rumadac surgery. These are adapted from the ACC/ 
MM guideks for comnary angiogr : $ty published in 1987.36 
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ment of this strategy in 201 consecutive patients being consid- 
ered for aortic surgery is presented in Fig 2. In this series, only 
58 (29%) of patients considered for aortic repair underwent 
further noninvasive testing with exercise andior dipyridamole 
thallium study. Siieen patients (8%) were referred for cardiac 
catheterization, with preoperative coronary revascularization 
performed in 13 (6.5%). This selected use of noninvasive 
testing and very selected use of revascularization resulted in an 
overall perioperative cardiac mortality of just 0.5%. 
To illustrate the cost implications of noninvasive testing and 
its potential cost-effectiveness, information from the Medicare 
databases was applied to the series by Cambria et al in Fig 2. 
If a cost of $567 per nuclear stress test is assumed, the 
accumulated costs of the selective screening of 58 patients is 
$32 886. In contrast, the cost of screening all 201 patients 
would have been $113 967, a net increase of $81 081 over 
selective screening. Based on an annual incidence of 500000 
major vascular surgical procedures in the United States, selec- 
tive testing could result in a savings of more than $200 million, 
compared with a p&cy of routine testing. If the accumulated 
costs of the tests and coronary interventions are taken into 
account, the overall cost of using this particular selected 
screening strategy in the 201 patients was approximately 
$590 206, or $2936 per patient. 
As described prekusly, there are no randomized trials 
demonstrating the etbcacy of screening and coronary interven- 
tions versus vascular surgery only. However, the low mortality 
qorted by Cambria et al and ot’lers in patients who had 
undergow coronary revasadarization suggests that such strat- 
egies improve survival. Using the Cambria data set as an 
example and assuming only one life was saved as a result of this 
strategy, the strategy would be at the expensive end of medical 
cost-effectiveness. lf long-term benefits are considered and thh 
patientlived10yeam.tbkstrategywouklhavecost559020per 
yearoflifesaved(igno@otbersubsequentco.sts).lfthe 
screening strategy was more s2xxud& per4aps resulting in 
twoIkressaved,thecostperyeardlifesavedwMlidhavebeen 
$29510, a figure that is much more consistent with other 
currently accepkd mediil therapies. Importantly, many of 
tbeseeostswoukllike.lybeincmvedatsomepointregardlessof 
consideratioo for vascumr surgery. In addition, Ribal e-t al** 
~along4ermsurvivalheneLofc4mmaryartery 
bypassgrafthginpatientswitht4e-ofperipheral 
vasadar disease and triple-vessel CAD. Therefore, by inchnJ- 
ing both sboit- and long-term benefi& such a strategy might 
prove to be cost-effeuive. 
Formal de&ion and coststTectiveness ana@s of this 
partMarquestionhavebeendoneandbaveyieldedhii 
varied res~Its.~J@-~@-~@ Bccaw tltc exact amount of, risk 
red~bomcomnary~tionandt4ccliaical 
populationsdiEerssontncbfmmoentertocenter,itisdi&ult 
todetermhrethe~ristsof aggrkwEcreeningalld 
treamem-tbebeaefitsintem?sofrisiredudioa . . ~,tIIenuJdeIsalI- ~0ptieoal-m 
reImau~.t3Jterecubtapadd, 
M?-ch IS, 1956910-46 
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16 patlen@ (6%) 
t 
PTCA: 2 PabjenLs 
CABG: 11 fmtimts 
(6.5%) 
+ 
TotalpMlphW?GildiaCardiacdeath 
1 palJenl(O.5%) 
Nudcarsbesstesting 
$457+11o=t567 
532666 
527 600 
$43 520 
wJ6200 
s590206 
Ft2.cosl asessment of a screening arategy for major vascular surgery patients. ‘1993 Medicare average alhed cbarge~ global kes. ‘Metlife. 
1992 ckims data from insurance pool. srarirticnl B&h. JanwMarcb 199U3. “Metlife. 1992 daimr data fmn inw- pd. Siewicfz/ 
lkdkrin January-March 1994;lO. %ktIife. 19!&!daimsdarakom iasurancepool.S&&jn. Jaauuy-March W&35. CPTmndkatecCurrenr 
F’mcedd Termindogy, FTCA, pera~taneous @amhtmii coronary angioplasty CABG. m utety I?lplrs surgeq. 
wbicb did mt support a strategy incorporatiog coronary ao- 
giograpby and wascuhrization used lower mortality rates 
than the used or reported in the other studies,“‘.J”.‘* 
Therefore, use of any decision and costeffectiveoess model ia 
a specitk situation defnmds on the comparability of local 
mortalityratestothosedtbcmodel. 
Fig 2 is meant to ihstrate tbe potential costs versus 
effectiveness of one such screening strategy. It is vitally impor- 
tant for the dinician to consider tbe axt impliitions of 
screening strategies, partiadarly in a field in which there are no 
randomired clinical trials evahmtii tbe impact of therapies on 
in tbe CAS registry from 19-B to 1981 and evelu* 
UndclweLlt major rloMmi& operatiom, 113 (7%) of wbkb 
werevascuhrprocedurerl%e&udygmupioch&d399 
parieots ai&a~t aogiographic evidence of a&axed CAD 
(group l), 743 patkots Mo had prior cownary bypasr gratiii 
beforeooocardiacpoadures(gnxrp2~aod458~wbo 
bad r+ign&m al@ppbk CAD (xi% bmi5al stamsis) but 
mpriorbjpaSsllrgery(gmup3).Theqx?Iativemor&y 
rates for norkwdii m in these tbree groups vere 
0.5%. 0.9%. and Z4%, recpeclively, aml m glwp dikreaa 
wcremledintbe-dperiapentiwMlorurdLc 
anil@lhTh!eoperaMlllortqrateingoup3was 
sigoificandybigkr(P=.(Kl9)tbaniaeitkroftkotkrtwo 
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tations of CAD (f<.OOl). Of these, 216 undement coronary 
bypass surgery (before vascular surgery) with a related mortal- 
ity rate d 5.3% followed by a mortality rate of 1.5% for 
vasdar surgery. Operative deaths with vascular surgery oc- 
aimed in 1 (1.4%) of 74 patients with normal coronary 
arteries, in 5 (1.8%) of 278 with mild to moderate CAD, in 
9 (3.6%) of 250 with advanced but compensated CAD, and 
in 6 (14%) of 44 with severe, uncorrected, or inoperable 
CAD.175 Studii such as these have generated interest in the 
posdble protective influence of coronary bypass surgery on 
subsequent surgical risk, even though interpretation of most 
retmqx&e studies is limited by failure to define the 
criteria for nonfatal MIS and 10 indicate whether or not 
serial ECGs and cardiac enzymes were obtained periopera- 
tidy. 
In attempting to baIance the potential risks versus benefits 
ofc!oroayarterybgpass~(oQBG)befofenowardi 
!3wgeay, the rddihml rdlort-term risks and long-term benefits 
shod be mderstood Long-term benefits of such strategies 
were not incorporated into two recent decisiin models’*iW If 
the long-term benefits were indude the value of preoperative 
revz&x&tionwouIdbebeForimtance, 
theEuropeanCoronqSurgeryStudyGroupl~basreported 
&enSing6nding5inasmallsubsetof58patientswith 
peripheralvasudardiseasewithinamuchlargerseriesof768 
menwhoweremndomly&gnedtoreceiveeithercomnary 
bP=surgety~- ntmgemmt for angina pectoris. 
wbiIethepreselmdinci4jentalperiphem)vascuIardise;sfe 
wasasso&edwithred&ionsintbe@eiuawivalratesfor 
eitkrsmgicalormedicaImaaagement dCAD,itskthence 
-fJespoeially -inpatientswhoreceivedmcdicaI 
therapyakwle.mti5thelong-termawivalratewas85% 
coromuy bypass surgely, lxnnpad with 57% for 
tTeamt (f=.uq. Rihal and lzdeagw’” have 
illZlbOlTthan2OOOptkOtS 
thenwkcompzlred 
witIlaJsumuy~aurgelyinpatien~witbbo&bcoroaary 
heartdiseaseandperipberalMsarlardii,~ 
include patients with the following conditions: acceptable 
coronary revascularization risk and suitable viable myocardium 
with left main stenosis, three-vessel CAD in conjunction with 
left ventricular dysfunction, two-vessel disease involving severe 
proximal left anterior descending artery obstnxtion, and in- 
tractable coronary ischemia despite maximal medical therapy. 
In patients in whom coronary revascularization is indicated, 
timing of the procedure depends on the urgency of the 
~onardiic surgical procedure balanced against stability of the 
underIying CAD. l%e decision to perform rexascnlarization on 
a patient before noncardiac’surgery to “get them through” the 
noncardiic procedure is appropriate only in a small subset of 
very high-risk patients. Patients undergoing elective noncar- 
disc prooxiures who are found to have prognostic high-risk 
coronary anatomy and in whom’ long-term outcome would 
likely be improved by coronary bypass grafting,*? should 
generally undergo revasc&ization before a noncardiac elec- 
tive surgical procedure of high or intermediate risk (Table 3). 
-cororrnrJ- 
?tammq ajtdaee. At present no randomized clinical 
trials have documented whether or not prophylactic coronary 
etasdkation with angioplasty before noncardiac surgery 
ieduces the incidence of perioperative cardiac events. Several 
retrospective series, however, have been repoficd. In a 5(r- 
patient series reported from Mayo Clinic,‘n coronary an+ 
@asty was perfolmed before noncardiac surgely (52% Wscadar 
pmc&ues)inp&ntsathighrSiforperioperativeam@ica- 
ti07*(62%werec&SedhighertbanCan&anHeartClassIfI, 
-%hadmulWsselctisease,andauhadabnomminoniwasive 
tests).Tenpercentreqdredurgentcoromuybypass~after 
mte19%.Whetherornotthisresultdilfersfromwhatmighthave 
dwithoutPTcAk~ 
EImoreaaI’~eonrparedthedtsdpreoperativeanv- 
nary zu@opky and tommy bypass surgery in patients 
identifkd foi elective abdominal aortic aneqsmorrhaphy. 
‘Ibis stud p r;. xospectively analyze the records of 2452 patients 
do UndLrwent abdomiil aortic surgery between 1980 and 
1990. orfy 100 (4.1%) had revascularization before aortic 
SWgl3&.and%%doftheseSylltpt~CAD.Eightyaix 
hadcWmarybypSssurgeryand14had~.lbere 
werenope@e&vedcathsinthisgronpattbetimeofaoi?ic 
surgery, mmpared with 29% pe* 
entire jp7mp (n=i452). Tbe patients is 
signScantly more c4xe- and two-vesxl Ice- 
veiaeldiseasethandidthebypamgmup.Iatec+iacevenls 
weremorefrequentiiltheaagioplast),gnmp.TllesmaIl 
oumbelsinIheao%ioplaJtrgToupaRdtbereuospectivcanaI- 
ysisoveralongperioddtimcnmkeintqreWonofthe 
huiJldkmmyoerdialinIarctim. 
*Mpcardh- 
tP-c.05 for drug wm% canml. 
Ailen et aP performed a retmpe4.tii am&is of 148 
patients who underwent angiopiasty before tmcardii surge9 
(abdominal 35%. vascular 33%. and orttPopedic 13%). surge9 
oectmedwithin9OdaysafterangioplastyinRTherewere 
four operative deaths (one cardiac), and 16 patients experi- 
enced cardiac cumpkahons during the tmcardiw surgery. 
cardiaccomplicationawerewereaJmmon illpatietJIso&kr 
rbanayeaatitIieinfomtationcanbegieanedfromthissman 
retmspeaivestuclyexoepttollotetbeiow~nceofeardiac 
deatbinpatietlIswhnhadcoronafyangioplastysolneIime 
before their itonwdii surgery. 
GivcnIheselimiteddata,tkdeoffat@ykbpnoper- 
ativeaxxmarya@ophtyinreduchguntwardphpe&ve 
cardiac c4?mpkatiarts remains iifampktely delkd. UnId 
fwtherdataareavaiMe,tkindicationsforiXAint&e 
periopetativeseningareidcntifalIothoscdevc~lrytke 
jointACUAHATaskFonxprwidiagpidclinesfortheureof 
PTCA in generaLi 
FOrptientswhohaveondergaK~cOrararyaa- 
&piastyjustbeforepqosedooncatdiacsurge9,thereis 
kltmttainty~~mlldl~shcmld~betoretbe 
noocardiac~iSperfaaleb&~oarudirW- 
geryformLuethamlto2montllawouldleadtoa~ater 
elmnceofeotnna9-att sikdtllus 
-iDense tlmclfatmsofperiopastiKisdwaha 
mAIIltcotkrrsmlte,,uterhlKmoilra#nraaltcthroat 
lf#isatIile*ofmislnoaIlih!fyIooaaIl~lnn8sto 
1to2*afteralawmly andtltmid 
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dejx&ion than treated patients (2%). In a nonrandomixed 
g&y, &tfxnackass gave oral metoprolol immediately before 
surgery and foBowed with intravenous drug during abdominal 
aortic aneurysm repair. Only 3% suffered an acute MI, com- 
pared with 18% for matched controls. In a later report the 
same author reported less intraoperative ischemia in patients 
treated with orai metoproIo1 before peripheral vascular 
surgeWss 
There has been onIy one study examining the role of 
caIcium chamtel blockers in this situation. The study was too 
smaI1 to allow definitive conch&m (Table 10). 
The use of nitrates is discussed in the section on intraop 
erative management. 
There are very few randomixed trials of medical therapy 
befotc nonarrdiac surgery to prevent perioperative cardiac 
compliitions, and they do not provide enough data from 
which to draw tirm amchrsions or recommendations. Prehmi- 
nary studies, however, suggest that appropriately administered 
&blockers reduce petioperative iscbemia and may ultimately 
be shown to reduce risk of MI and death. Cleady, this is an 
ah&e. 
recent past to control 
sympmms of angina or patients with symptomatic arrhythmias 
or 
rative a.wsment identifies untreated hy- 
zs mmnary disease, or major factors for 
C&m UL Contraindication to @lockade. 
v&e surgery 
There is little informaticm about the appropriateness of 
vabtdar repair or repiaQment before a nonmud& surgical 
proc&re is undettakeu Clinical experience indites that 
patientswithvabnlarheartdiseaseseveteenoughtowarrant 
.wgical treatment should have valve surgery before elective 
zhcmcdk surgery. RecentIy it has beea suggested that pa- 
tients with severe mitral or aortic stenosis who require urgent 
ltoncdknulpry,suchaaintestinal resedon for ksii 
causingserkmsgastrohttestma~maybenefitfrom 
catheterba&onvaWopUyatleastasatemporizmgstep 
to &ace the operative risk of di surgeryamJ~ 
unfortuoateqr, there are no coatNued studies, and the risks 
of baIloon aortic valvuloplasty in older patients are 
with managing Avular heart disease during 
labor atd detivcry pKwides bights into the appmach to 
JACC Vol. 27. No. 4 
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tion. Therefore, increases in blood pressure should be pre- 
vented. and left ventricular afterload should be optimized with 
vasodilators. In contrast, patients with significant aortic or 
mitral stenosis often do not do well with the increased hemo- 
dynamic burden of pregnancy. If the stenosis is severe, percu- 
taneous catheter balloon valvotomy should be considered as 
definitive therapy or as a bridge to carry the patient through 
; .egnancy, labor, and surgical delivery. Excessive changes in 
intravascular volume should be avoided (see also section III, 
“Valvular Heart Disease”). 
ArrhythmiaJConduction/Device 
In the perioperative setting cardiac arrhythmias or conduc- 
tion disturbances often reflect the presence of underlying 
cardiopulmonary disease, drug toxicity, or metabolic derange- 
ments. In patients with documented hemodynamically signih- 
cant and/or symptomatic arrhythmias, ambulatory ECG mon- 
itoring or specialized electrophysiological studies of the heart 
with guided drug therapy may be indicated to reduce recur- 
rences of arrhytbmias.190~i91 Supraventricular arrh@m& may 
require either electrical or pb armamlogid card&et&m if 
they produce symptoms or hemodynamic compromise. If car- 
dioversion is not possible, satisfactory heart rate control should 
be accomplished with oral or intravenous digitalis, @- 
adrenergic blockers, or calcium channel blockers. In patients 
with atrial fibrillation who are on oral anticoaguUon therapy, 
it may be necessary to discontinue the anticoagulant several 
days before surgery. If time does not allow and it is important 
that the patient not be on anticoagulants, the effect ofwarfarin 
can be reversed by parenteral vitamin K or fresh froxen 
plasma.& Ventricular arrhythmias, whether simple premature 
ventricular mntractio~ complex ventricuhu ectopy, or non- 
sustained ventricuhu tachycardia, usualIy do not require ther- 
apy except in the presence of ongoing or threatened myocar- 
dii ischemia or moderate to severe left ventricular dysfunction 
in which such arrhythmias represent a significant risk factor. 
Sustained or symptomatic ventricular tachycardia shoukl be 
suppressed preopzratively with intravenous lidocaine or pro- 
cainamide. The indiitiorts for temporary pacemakers are 
ahnost identical to those previous& stated for long-term per- 
manent cardiac pacing.i~ Patients with intraventricular con- 
ductii delays, bifascimdar block (right bundle branch block 
with left anterior or posterior hemibiock). or left bundle 
branch block with or without lirst degree atrioventrictdar block 
do not require tempotaty pacemaker implantation in the 
absence of a bistoty of syucope or more advanced atrioven- 
triadar bloiAri Permanent pacemakers may need to be 
checked for end-of-life indicators and programmed to verify 
q ormaifunctkmandthepatient’sievetofpacm&erdepen- 
dency.InpatientswhoaretotaIly 
eiectmcauteryposesaspeciaIpm&mandsbotddbeusedonly 
brietly.wiihtheinditferentpoleplaeedasfarawayfmmthe 
paammhrand heart as paJebIe. In gtlamdmdept 
patiea~aofbipolarpacingwiIiminimiaetberiskoftaaed 
c-Iety..AlsqtItet&toboti~ 
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ited mode such as AOO, VOO, or DO0 with programming or pneumatic compression--will depend on the risk of venous 
a magnet prevents unwanted inhibition of pacing. Implanted thromboembotism and the type of surgery planned. Table It 
defibrillators or antitachycardia devices should be pro- provides recently published recommendations for various 
grammed off immediately before surgery and then On again types of surgical procedures.‘“l-lW 
postoperatively to prevent unwanted discharge due to spurious The noninvasive techniques-impedance plethysmography 
signals that the device might interpret as ventricular tachycar- and real-time compression ultrasonography-are effective ob- 
dia or fibrillation. jective tests to exclude ciinically suspected deep venous throm- 
bosii and are best used for this purpo~.~~7J* Routine screen- 
Preoperative Intensive Care 
ing of all postoperative patients with a noninvaskr technique is 
not as cost-eflective or efkient as appropriate antithrombotic 
GewemlcoRddrmtiorss nrophylaxis for moderate- and high-risk patients.~‘+ IvI 
Prcoperativc invasive monitoring in an intensive care set- The prevalence of chronic occlusive peripheral arterial 
ting can be used to optimize and even augment oxygen delivery disease rises with increasing age. atkcting more than 10% of 
in patients at high risk. It has been proposed that indexes the general population older than 65 year+ and as many 
derived from the pulmonru) artery catheter and invasive blood as half of persons with CAD.~‘l Protection of the limbs 
pressure monitoring can be used to maximize oxygen delivery, from trauma during and after surgery is as important for those 
which will lead to a reduction in organ dysfuuction. with asymptomatic arterial disease as for those with 
*dE- claudicatiou. 
Only me study has pmspectively evaluated tbe ekacy of 
preoperative jmhnouary artery catheter utilization and optimi- 
zation of hemodynami in a randomii trial with cardii VIII. ADestw coosidelatioas and 
complications as a major outcome. Eighty-nine patients under- Iwaoperative M4umgement 
going infrainguinal arterial bypass procedures were randomly The pat-1 events thaw occur with the trauma of 
assigned to groups that received a pulmonary artery catheter surgery and the perioperative administration of anesthetic and 
aud (I) p: prative optimizaion overnight in the intensive pa&relieving drugs ofien affect the pbysiorogy of card& 
care unit, (2) for 3 hours preoperativeiy by the aue&esk care functionaJld~iootogreatdegrees.specificintegratkm 
tq or (3) intraopefative monitoring based sole@ ou el%cai 
irldicationa’~~ When MI or tlunarrhythmogenic rardiic death 
oftbesechaagffwirhtbe~hamieaalllalionlsa~unro 
itselfaruibeyoudtbescopeoftbeseguideliiTheinforma- 
was used as the outcume, no significant differences were 
demonstrated. 
tirmprovidedbythecardioyarularcou5uhantneedstobe 
integrated by the w surgeon, and postoperative 
caregivers in preparing an individualized perioperative 
Based cm the scant wide=, preoperative preparation in au maruge=nt * 
intensive care unit may benefit certaiu high-risk @en& lllcrearemanydiuere~tappoadrestothedetailsdthe 
particularly those with decompensated CHF. Preparation of ancslheticcareofthecardcardiacpiuienLEachhasimplications 
such patients should occur under close supervision. regarding anesthetic and intt-aopemtive mattitoring. IO addi- 
tic4t.msudyh&cieatiyde~ a~iaautmnu 
Vew~~h/Peripheml Armial LXsease fnmt&lazdthefobwiugtechaiqua:apllmooaryartery cathe,sT~munita.tramsopbagcat~ 
Two pe.ripbed vasdar disorders that merit attention ph~@),~w llim#uk-.tbe~of 
pzeoperatively are venous thromboembofism an4 iu the el- aocsthetirandiaavlpentive rmnitrsk&rtkfttutheGsae- 
ripherd arterial disease. timoftheane~eauetearn~~tmy 
wed to be planned ai,d in some 
lyforperyomwithchuicalcizWm- 
stances assuciated with postopetak venous thrombocmbo- 
iisut.TlleseawrelatesofthromboembdierbLhdudead- 
ties~obes&vrm35E choinof~re?c~dAgrrrl 
pefvi&hipalegc4Jnphde8aoprdnd-iab Mdtjp&mdaahm~tbeinducmdraattKtk: 
statesban4p* rhJgsand~ooardbEmorbidky.la~ 
bytkremtt slLldk50iuarc~potienq~-d~~~ 
19s ppcairtlralcthemu6t~~ 
itapparrthcreisooonebest~~potcdivc 
4iaed~k?Knm~tbd~beaariacndie* 
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Taft& Il. General Guidelines for P&operative Prophylaxis for Venous ThromboemMism* 
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Recurnmendation 
Early ambulation. 
Es: LDH (2 h preopxatie@ and ewy 12 h after). or IPC (intraqxratively and 
poaperativcly). 
LDH (every 8 h) or LMWH. WC if prone to wound bleeding. 
LDH, LMWH, or dextran combined with IPC. In selected patients, perioperatiw 
warfarin (INR 2.0 3.0) may be used. 
LMWH (postoperative, subcutaneous hvice daily. lixed dme unmonitored) or w&tin 
(INR 2.0-3.0. started preaperatively or immediate!y after surgery) or adjusted dose 
&ractiinated heparin (started preoperatkly). ES or IPC may provide additional 
e6icacy. 
LMWH (pcatoperatiie, s&cutaneous. t&e daily. faed dose unmonitored) or IPC. 
LMWH (preoperative, subcutaneous. tixed dose unmonitored) or warfarin (INR 2.0- 
3.0). IPC may pr&le additional benefit. 
IPC with or without ES. Ccmider addition of LDH in high-r& patients. 
Adjusted dcse heparin or LMWH for prcphylaxis Warfarin may abo be effective. 
LDH. ES. and IPC may have benefit when used together. 
IPC, warfarin, or LMWH when feaii. serial surwiIIaap with duplex 
ult- may be useful. In selected vev high-risk patients. consider prophyiac- 
tic caval filter. 
Esil%dica~~ elastic stocldngc LDH. low& subcuraneaa heparin; IPC, intermittent pneumatic compressiq LMWH, low molecular Weight 
+ili&J amditk atwciated +tb iacrwed risk of emus thmmbwmbdbm: z&anced age: prolonged immobility or paralysii previous venous tlmmtbwm- 
bolisn: majot smgery of awnneh p&is. ot Iowa extremity; ohedty; varimse veins; connive beart failure; myocardii infarction: St* fmcture(s) of 
~pelrisW~ork& sMesaltd~~csmrgenusc. 
pioperative plan. opioid-based anesthetics have become 
popular because of the cardiovascular stability associated with 
theii use. The use of high doses, however, is associated with the 
need for postq-Jerative ventib#ioo. sii weaning from the 
~&atorinaniatetGxcaresettiqhasbeeaassociatedv4th 
myoc&ial i&em& this featare is important in the overall 
riskkftteqnatioa 
All iobalatiooal agents have eardiovaseular effect!+ iodud- 
of nymdial eontradlity and afterload reduc- 
etlamn% aud isotlurane-did not iutluence out- 
tiiak.~Tbeeardiavsscularsafetyofthe 
-, is tlot as well 
prcload becomes Bornpromised or blockade of the cardioaccel- 
ericon oams. 
Monitored anesthesia care by an anesthesia caregiver in- 
ch&s the use of local anesthesia sy#mented with intrave- 
nous sedation/aualgesia and is believed by some to be associ- 
ated with the greatest marginal safety. In a large-scale shrdy, 
however, monitored anesthesia care was associated with the 
highest incidence of 30day mortality.~ This finding may 
reflect a strong selection bias io which the patients with 
signdicant coexktiig disease were selected for surgery with 
tmmitored anesthaia cm rather than other anesthetic tech- 
niques. Although this tech@ can eliminate some of the 
undesirable effects of general or neuraxial anwthesia, it pro- 
videspoorbkxkadeofthestres4responseunlessthelocal 
anesthetic provides profound anesthesia of the affected area. If 
the local anesthetic block is less than satisfactoty or cannot be 
used at all, monitored aoesksia care could result in an 
inmat& iacideoce of qvcardial ischemia and cardiac dys- 
ftmuionaxopaAwithgetteralorqioaalaae&&a.To 
adkvethedesifedeReeCewsssedathieanoceur.There- 
fore, there may be 110 sigoikant difkence ia overall safety 
withmo&tmedanesk&aeare,andgeneralorregkmalanes- 
thesiamaybepreferable. 
JACC Vol. 2. No. 4 
March 15. i9%910-48 
cardiac events in noncardiac surgical patients occur postoper- 
atively, the postoperative period may be the time during which 
ablation of stress, adverse hemodynamh and hypercoagu- 
Iable responses is most critical. Although no randomized, 
controUed study specihcally addressing analgesic regimens has 
demonstrated improvement in outcome, patientcontrolled 
anatgesia techniques are associated with greater patient satis- 
faction and tower pain scores. E@hual or spinal opiates are 
becoming more popular and have several theoretic advantages. 
Several studies have evaluated general anesthesia!iitravenous 
analgesia compared with epidural or epidurzi cor.:bined witb 
&II4 aner&eWepidural analgesia. The patiens having 
epidural anesthesia/analgesia have demonstrated lower opiate 
dosages, better ablation of the cated&mme respome, and a 
ieshyperooagulablestate.honeshIdyofpatiennImdergoing 
lowerexkmityvascukrbypossproeedures,thelIscofepidural 
ane&csia/analgGawasassociatedwithaknwxinc&oceof 
cardiac~,however,thishndingwasnotco&medin 
another study.mm Most @ortan& an etTeUive an&e&z (ie, 
onethatbhmtsthestressrespome)regimenmustbeindudedin 
&eperiopmtiveplan. 
Intmopemtive Nitqfyccmin 
Gemed- 
Nitroglycerin has been shown to reverse myocardial isch- 
emia intraoperatively. fntraoperative prophylactic use of nitro- 
glycerin in patients at high risk may have no effects hovvcver, 
or may actually lead to cardiivascular decompensatioo 
through decmmes in preload. Additionally, nitrog&erin paste 
or patch may have uneven absorption intraoperatively. Af- 
cordinglyn~nsbouldusuaflybeadministeredinthe 
intravenous formulat* if required. 
Ike venodifating and arterial dilating effects of nitrogfycer- 
in are mimicked by some anesthetic agen& so tbat UK 
combiition of agents may lead to sigoiticant hypotemioo and 
myocdd ischemia Therefore, nitt@ycerin shouid be used 
only when the hemodynamie effects of other agents being used 
areconsidered 
ieshaveevahJatedthevahieofpta 
phyiactic nit@ycerin infusmns for hi-risk patients, iodud- 
ing two studies in noncardiac surgery patients (Table 
11). Is*l~oBDR Only one study, perfomed in patients with 
stabkanginaundngoingQIotidemiarterectomy,~- 
stratedareducedioc&aceofmtmoperativempcardialiscb- 
emiaintbegroupreceiving1.0lrgllyperminuteofrdtrog&- 
erin.Neiidtk+nOsmai:PEldies-tedany 
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angina. The recommendation for prophylactic use of nitroglyc- 
erin must take into account the anesthetic plan and patient 
hemodynamics and must recognize that vasodilation and hy- 
powlemia can readily occur during anesthesia and surgery. 
Gha III. Patients with signs of hypovolemia or hype 
tension. 
Use of Tmmesophageal Echowrdiogmphy 
Geftd- 
The USC of TEE has become increas~ngty common in the 
operating room for cardiac surgery hut is less frcquentfy used 
in noncardiac surgery. Multipk investigations have docu- 
mented tbe improved sensitivity and specific&y of TEE for 
detection of myecardial ischemia compared with electroczdi- 
ography or pulmonarycapilkuy wedge pressure measurements 
Most studies have used off-line analysii of the TEE images, 
however, and automated on-line detec&n may increase its 
value. 
S-FYofE- 
Therearefewdataregardingthevah4eofTEEdetecied 
wall motion abnwmalities to predict cardiac morbidity in 
noncantiaf surgical patients. In two recent studies from the 
samegmIp,intraoperativewaomo6onabr~iwere 
puorprediiofcardiacmo&dity.~~“~lrfnooestudyim&- 
ing332menundergoingrroncm&smgeries,TEEdemoo 
strated an odds ratio of 2.6 (95% CL 12 to 5.7) for pcdicting 
perioperative cardiac events.210 
requires additional traini~ At 
presenttherearenoannmer&iyavaiWere&irnemonitom 
ofquarItitatirewaomotion.~rrgioarlwallmotkln 
abnom&itiesinahigh-riskpatientsuggestmyocPntialisch- 
emia.resohrtionofmyocanWischemiamaynotresuhin 
iirqowmntofwaumotioa. 
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There is currently insugicient evidence to determine the 
vahte of prophylactic placement of an intra-aortic balloon 
~nte+dsation device for nigh-risk noncardiac surgery. 
IX. Perioperative SurveiMance 
Although much attention has been foeused on the preop- 
erative preparation of the high-risk patient. intraoperative and 
postoperative surveillance for myoeardial isehemia and infarc- 
tion, anhythnii and venous thrombosis should also lead to 
reductions in morbidity. Postoperative myocardial irhemia 
has been shown to be the strongest predictor oi perioperative 
cardiac morbidity and is rarely accompanied by pain.’ There- 
fore, it may go untreated until overt symptoms of cardiac 
failure develop. 
The diagnosis of a perioperativs .?r_! has both short- and 
Iong-term prognostic value. Traditionally. a perioperative MI 
has been associated with a 30% to 50% perioperative morta!ity 
and has recently been associated with reduced long-term 
stnvival.*~~~~4~~5 Therefore, it is impormnt to identify pa- 
tients who sustain a p&operative MI and to treat them 
aggmsively since it may reduce both short- and long-term risk. 
htmoperative and Postopemtive Use of Pulmonary 
cry catheter can provide siguificmt in- 
formation critical to the care of the cardiac patient. Its use, 
however, must be balanced against the cost and risk of 
compkatious from insertion and use of the catheter, rhii are 
low when the operators are experienced. Several studii have 
eduated the benefit of pulmonary artery catheters in both 
-aiabandthosetISiIlghiStO~COIItlOlS.Illp- 
dents with a prior Mk when pedqe&ve care included 
puImomqarteryandintensivecaremouitoringfix3days 
postqemtively,therewasalouerhk4eneeofrehtfar&m 
tbaniI4-amtrok.~otherehaagesinmanagemeat 
axurreddmingthepetiodtmdersMy,ho98ever,inel~gthe 
iweaseduscof&aQewrgicsympatheticblocbade.Inpaftie- 
!2!ar,pati+swithsigt6andsymp@msofheartfaihuepreop. 
eradveIy,wbhaveaveryhigh(35%)pmtoperativeiueidence 
,mightbe&tfromiIlvask ~modynamic 
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bidity in infrainguin-l surgery patients when monitored by a 
pulmonary artery catheter either from the evening before 
surgery. 3 hours before surgery, or only if clinically indicated; 
however, the soups with the pulmonary artery catheter had 
fewer intraoprative hemodynamic disorders.‘9J 
Reromm~ 
Practice parameters for the intraoperative use of a puhno- 
nary artey catheter have recently been published by the 
American society of Anesthesiologists.riX These parameters 
approach the decision to place the pulmonary artery catheter 
as the interrelationship between three variables: patient dis- 
ease, surgical procedure. and practice setting. With regard to 
the surgical procedure, the extent of intraoperative and post- 
operative fluid shifts is a dominant factor. 
I- use t?fplrlRwwrJ Artery cathdm2’8 
C&xcr i. Patients at risk for major hcmodynamic distur- 
bances that are most easily detected by a pulmonary artery 
catheter who are undergoing a procedure that is likely to cause 
these hemodynamic changes in a setting with experience in 
interpreting the results (eg, suprarenal aortic aneurysm repair 
in a patient with angina). 
Fuss II. Either the patient’s condition or the surgical 
procedure (but not both) places the patient at risk for hemo- 
dynamic disturbances (eg, total hip replacement in a patient with 
chmnic renal insu%ency). 
Cks LfX. No risk of hemodynamic disturbances. 
Intmoperotive and Postoperative Use of 
ST-Segment Monitoting 
GmmliconriQlrrrions 
Some contemporary operating rooms and intensive care 
unit monitors incorporate algorithms that ,&orm real-time 
anaIy& of the ST segment. in &&tion, realtime ST-segment 
maiming via telemetry or ambulatory ECG (Holter) moni- 
tars with alarms is being developed. Numerous studies have 
demonstrated the poor ability of physicians to detect sign& 
cant ST-segment changes compared with computerized or 
o64ine analysis If available, computerized ST-segment hend- 
irtg is superior to visual interpretation. Although proprietary, 
martyofthesea@ithmshavebeenvaIidatedfortheirability 
to aecurateIy deted ST-segment shifts 
syI*IprldE+-@ 
VirtuaIly all studies examining the predietii value of 
intraoperative and postoperative !lT-segment changes have 
been performed using ambulatory ECG recorders. Using 
fehospeche analys& investigators have found PQulperatiw 
sr-segment changes indiicative of #lqam&l ii?hmia to he 
the~h&pendentprediiofperiopaativccardkx 
eventsinhi$l-Iisknoncar~surgeIypadentsinlmdtiplc 
shIdkwitfl~ofpm&mgcddmationking~ 
e@(j * &fea$ed &&‘“‘9tBo &f&j@gy, pQg(qep 
atksr~dMuIgeshavebcenshowntopredictu¶rsc 
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occur during elective Cesarean sections in healthy patientr”! 
Because these changes were not associated with regional wall 
motion abnormalities on precordial echocardiiaphy, in this 
low-risk population such ST-segment changes mzy not be 
indicatiie of my-dial ischemia and C4D. 
Proper use of computerized ST-segment anarysb in appro- 
priate hirisk patients may provide increased sensitivity to 
detect tnyocardial ischemia during the perioperative period 
and may identify patients who might benefit from further 
postoperative and long-term interventions. Therefore, com- 
puterized monitoring of rhe ST segment cdn provide useful 
information in appropriate high-risk patients, if available. The 
cost-effectiveness of annputerized ST-segment am&is for 
reducing perioperative morbidity, however. bas not been doc- 
umented. Further research is required. 
Sutveiliance for Penbpemtive 
Mpcardial Infarcti 
Multiple studii have evaluated prediiive factors for a 
pe.r&erative MI. Ilie presence of clinical evidence of mm 
my artery or peripheral vascular d&se has been associated 
with an kreased incidence of perioperative MI. Factors that 
inmase tbe risk of a perioperative MI have been discus& 
previously. Because of the incmas;d risk of both short- and 
long-term mortality from a perioperative MI, accurate diagmv 
sisisimQomnL 
be documented by serial ekctmcar- 
dii~ cardi@ enzyme adyses, mmpadve vcn- 
tricdo* studies before and after surgery, and radio& 
topic studies speeilk for myocardial necro&PublishedECG 
criteria for MI vary, however, with some authors 
IMe5otamde&ria,othensimply~new 
Qwaxs,andotbersnotspeeifjkqtheECG&eria.Nonspe- 
cificSTandTwavechangesarecommonintbeimmediate 
postoperative period but have not been assnciarti with in- 
creased m4rkdity.~ la the analyskofcardiac ew2yme criteria 
numennfs‘~are-to- CK-* and 
tbethnsboldatwtkhanenzymefiseis4xmsi&&abnormal 
iSVakbk.l~addiiCK-MBhasbeensbav7~obenkaxd 
ffomnonc&ksoumsinpatieatswithi&emiclimb5w 
undergoing amtic sqefy, the group at highest risk for a 
pcriopcntiJc MI. Fii, new mvoardiaGsptciFr enzyme5 
tbaI2recuRentlybtingdcvclopkdlmdcvaluatcdiIlthe 
pelioperative patient. slcb 8s card&E tlupdn-I a troponin-T 
orcic-MBisof~requinfurtberstudybeforedete~ 
theirusefulnemin~~* 
sa*rurd- 
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pending on the diagnostk criteria used. A stra:egy usmg an 
ECG immediately after the sor@cal procedure and on the finr 
and wcond da y’ pos:operativeh had the hignesi sensiti\i+. 
Qrategies inciudirg the serial measurement of CK-UB had 
higher false-mtive rates uithout higher sewhi\ it&. la con- 
trat. Rettke”’ reported ihat orerall wnival war aszmiatfd 
with the degree of CK-MB elevation in 348 patients undergo. 
ing abdominal aortic aneurysm repair. Gth higher levels 
associated with worse survival. Yeager et al’l’ cvaiuatsd th 
prognostic implications of a pzrioperatk Ml in a uxi63 d 
IS61 major vascular prwcdures. l%ew autbon found that the 
incidence of wkquent VI and coinnary arter) rmwxtarrita- 
tion uas $@icanrl) higher rn patients who suffered a pnop- 
eralive MI. except in rhe Wt who or@ demonrtra:ed an 
elevated CK-MB uitbout ECG change< or wrdimawurlar 
symptoms. 
Further ewluarion regarding the optimai btrareg for .i ‘: 
veillance and diagnosis of perioperative MI is requmxl b&.ne 
ooe method is advocated In patients u;itbout evidecr of 
CAD, suweiltance shwld be restricted to patienrs who dewb 
periopxative signs of cardiiascular ~sfuxtion. In p.&ent~ 
with known or wrpeaed CAD undergomg surgical procedt.m 
associawd with a high inckknoe of cardknasular morbi&y. 
ECGs at baseline, immediate~ after the SurgicA prc4xdurr. 
and daily on the fim 2 days postoperative& appears to k the 
most cost-effde urategy. Measurement5 of cardiac en 
are best resewed for patients at high risk or those &J 
demonstrate ECG or berm@namic ekknce of cardi~ascular 
dys-. 
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channel b&ken+ or @ldien with sbwvit& of henn ra~c dnd 
a~rdiovetim. Un~foa~l or multifocal prrnwture ventricular am- 
tMctkma do not merit vigorous therapy Cotnpkx venlricular 
ectopy such aa mxm&ned or sustained venttie&u tachycardia 
fUpiKSmKeVigOtUUStherapy.~itldrepmenceOf 
ongoingatbreatenedmyocardialischem&kftventriaJar* 
limtim, or valvdr heart dii. Ventricu&r arr~hrnias may 
nqond to &awxous &Hock* liiine. pm6namii. or 
ammdam~.‘~ Electrical carditwersion should be used for supra- 
ventricular or ventricular arrhythmia5 cauting hemodynamic 
a)mptxwn&. 
X. Postoperative Therapy/Future 
Management 
Whenever fcasihle, postoperative management should in- 
clude the assessment and management of any risk factors for 
CAD, heart failure, hypertension. stroke, or other cardiovas- 
cular disease that may have been identified in the preoperative 
period. Such factors include hypercholestcrolemia, smoking, 
labile or sustained systemic arterial hypertension, borderline 
hyperglycemia or diabetes mcllitus. obesity. physical inactivity, 
FUXW alcohol consumption, carotid bruit, peripheral vascular 
disease, heart murmur\, abnormal EC’G, cardiac arrhythmia or 
conduc$on abnormality, perioperative &hernia, postoperative 
Ml. abnormal pulmonary function tests, or a positive family 
history of premature cardiovascular disease. Appropriate plans 
&hot&l be made for the postoperr;livc evaluation of any of 
these findings and the imtitution of appropriale diagnostic 
tests and management plans. In particular, patients who SUM- 
tain a perioperative Ml or develop evidence of myocardial 
ischemia should be carefully evaluated. These patienb have a 
tuhtantial risk of .MI an&or cardiac death over the subsequent 
5 trl It1 years. Accordingly. whew patients should be csrefully 
cvdhtcd ty noninivsivc testing 1~ determine left ventricular 
fun~non attu whether or not they huve c%dcnce of myocardial 
&hernia on exertion or during pharmacological stre%s.~’ Some 
palienta may benefit from coronary revascularization >y 
CABG or FICA. 
Most patients who have documented arteriosclerosis will 
benefit from phanacolqical agems to lower low density 
lipoprotein (LDL) cholesterol levels, increaw high denslty 
lipoprotein (HDL) I;4,. or horh The goal %houltl be 111 lower 
thr LDI. lore1 to IL.*\ than 11%) mddl. (2.6 mmol/dl.).~~‘~ 
In genctal. the indicatiuns for add~tion~~l ~scrcening or 
te\:mg &re dependent on individual patient characteristics It is 
mtp)rtant that tke physician(a) rcspon6hic for the long-term 
carr of the patient he ~III full mk~rmatic~u about my cartlio- 
va~ular iibnornaitti~\ (,r rt\k factor\ Ior (‘Al) ~tlent~ficd 
durmp lbr pcr~~pcr.~t v’c peritnl. 
X 1. Conclusions 
Successful perioper&r: crzhtdh7 and manigwrcw UF 
high-risk cardiac patienta undergoing noncardtac surgery rc- 
quirer careful teamwork and communication between surgeon, 
enesthc4ogi~t, the patient’s primary care phpician, and the 
c~tttsultant. In general, indicrtions for further cardiac trsting 
and treatments are the same as in the nonoperative setting. but 
their timing is dependent on several factors. inch&g the 
urgency of noncardiac surgery, patient-specific risk factors, and 
surgery-specific considerations. The use of both noninvasive 
and invasive preoperative testing should be limited to those 
circumstances in which the results of s sh tests will clearly 
affect palient management. Finiilly. for many patients, noncar- 
disc $urgety represents their first chat,ce to rcccive an appro- 
priate assessment of both short- and long-term cardiac risk. 
Thus, the amsultant best serves the patient by making recom* 
mendations aimed at Iowcring the immediate perioperative 
cardiac risk as well as assessing the need for subsequent 
posttrpcrative risk stratification and interventions directed to 
modify ammary risk faders. 
XII. Cardiac Risk of Noncardiac Surgery: 
Areas in Need of Further Research 
l Role of prophylactic revascularization in reducing peri- 
operative and long-term MI and death and its cost- 
effectiveness 
* Costeffectiveness of the various methods of noninvasive 
testing for reducing cardiac complications 
l Establishment of efficacy and cost-elfectiveness of vari- 
ou:, medical therapies for high-risk pdticnts 
l Estabbshmsnt of optimal guidelines for selected patient 
suhgro:tps. particularly the elderly and women 
l Establishment of the efficacy of monitoring patients for 
myocardial ischemia and infarction, particularly the role 
of monitoring in affecting treatment decisions and 
outcomer. 
Appendix 1 
Methods 
The\c guitlelincb arc hvvd on a Mcdlinc scerrch of the English 
htcraturc from 1075 through IVV4, review of sclccled journals frum 
I’NS, .mtl the expert opinton\ 01 I? committee members repre.senting 
variou\ diriplines of cardiovascular care. including general cardiolugy, 
noninvasive testing, vascular mcdicinc. vascular turgery. ancsthesiol- 
ogy, and arrhrhmia managemet*t. !n addition. draft guidelines were 
\uhmittcd for critical Y+W and amendment cl phpicians rrpresent- 
mp intcrnid mcdrme. lumily pm&x, nuclear curdloklgy. general 
uugcry. and anc9lti~:si~~lr~gy ii% well as erecutivc &kern rcpreu!nting 
the hmeriwl (iNqtv *tl t’ardiology and the hmcrican ltran hwci- 
HIIltl. ‘Thr final tk%umcnt rcprc%nts the eighth iteration over 1X 
month\. uhxh mcluded six Jr& m ctrmmittce and tw11 additional 
drafts to incorporate key tinding from external rev&. 
A large proponiorl of the dala used to derclup thru: guidelines is 
bared on obuxvatitmal or retrcnpertivc studies or kntwtedge of 
rumdt+xn:.lt cri c&kwaccular dbr)r&n in the nencwrative utting. 
While the collective knowledge rurrnunding the identification of high- 
JACC Vet. 27. No ( 
Mrrcb IS. IwfKYIU-48 
and low-risk paticnts uning perioperntive clinical rind no&a&e 
evaluation i8 nukantial, very few prospective or randomized studier 
have been pertormed that establish the value of tests or treatmentx on 
perioperative outcomes. Therefore. data are presented in a tabular 
format, and whenever pokble retlect the value of a test or interven- 
tion for similar outcomes of a perioperative MI or cardii death. 
Because the studies were rarely randomized amtmlkd trials defini- 
tions of a perioperative event varied, invesdgston were rar$y blinded, 
and many inherent selection biases existed. the task force haJ chosen 
no1 IO provide an aggregate synthesis of ~bc data in the form of a point 
estimate or m&-anal@. On the olhcr hand, prrscntation of lhe origimd 
Dada pnwidcs substantial supp.a! for thaw recc~mcndalions, 
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